CN118835255A - Preparation method and device for multiple amphiphilic molecule layers - Google Patents
Preparation method and device for multiple amphiphilic molecule layers Download PDFInfo
- Publication number
- CN118835255A CN118835255A CN202410598638.3A CN202410598638A CN118835255A CN 118835255 A CN118835255 A CN 118835255A CN 202410598638 A CN202410598638 A CN 202410598638A CN 118835255 A CN118835255 A CN 118835255A
- Authority
- CN
- China
- Prior art keywords
- flow channel
- solution
- micropores
- opening
- meniscus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 79
- 239000012528 membrane Substances 0.000 claims abstract description 124
- 230000005499 meniscus Effects 0.000 claims abstract description 84
- 238000000034 method Methods 0.000 claims abstract description 84
- 239000000243 solution Substances 0.000 claims description 274
- 238000002347 injection Methods 0.000 claims description 39
- 239000007924 injection Substances 0.000 claims description 39
- 238000009736 wetting Methods 0.000 claims description 14
- 150000003904 phospholipids Chemical class 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 230000009471 action Effects 0.000 claims description 4
- 230000009916 joint effect Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 95
- 239000010408 film Substances 0.000 description 56
- 239000007788 liquid Substances 0.000 description 39
- 239000000463 material Substances 0.000 description 29
- 230000008569 process Effects 0.000 description 25
- 230000015572 biosynthetic process Effects 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 238000010586 diagram Methods 0.000 description 14
- 238000012545 processing Methods 0.000 description 13
- 239000007864 aqueous solution Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 12
- 229920006324 polyoxymethylene Polymers 0.000 description 12
- 239000002052 molecular layer Substances 0.000 description 10
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- -1 polyoxymethylene Polymers 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 229930040373 Paraformaldehyde Natural products 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 4
- 230000013011 mating Effects 0.000 description 4
- 238000000520 microinjection Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 229920000867 polyelectrolyte Polymers 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229920004943 Delrin® Polymers 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920000052 poly(p-xylylene) Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920000428 triblock copolymer Polymers 0.000 description 3
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000007990 PIPES buffer Substances 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000013554 lipid monolayer Substances 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 238000003703 image analysis method Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000001755 magnetron sputter deposition Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002120 nanofilm Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000012994 photoredox catalyst Substances 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B3/00—Electrolytic production of organic compounds
- C25B3/01—Products
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B15/00—Operating or servicing cells
- C25B15/08—Supplying or removing reactants or electrolytes; Regeneration of electrolytes
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
- C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
- C25B9/60—Constructional parts of cells
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
本发明涉及一种快速制备两亲性分子层的制备方法及制备装置,包括步骤:S1提供用于制备多个两亲性分子层的制备装置,制备装置内设有多个微孔,以及能够使得溶液流向微孔的流道,制备装置内还包括电极层,使得流向微孔内的溶液可以与电极层相接触;S2向流道内加入第一极性溶液,使得第一极性溶液进入至少一个微孔,并与电极层相接触;S3依次向流道内加入膜溶液和第二极性溶液,使得膜溶液在流道内形成弯月面;S4向流道内加入第二极性溶液,使得第二极性溶液推动膜溶液移动并流经第一极性溶液与电极层相接触的至少一个微孔,膜溶液中的两亲性分子在相应的微孔上形成两亲性分子层。本发明提供的方法操作简单、安全,所选用的制备装置生产成本低。
The present invention relates to a preparation method and a preparation device for rapidly preparing an amphiphilic molecule layer, comprising the steps of: S1 providing a preparation device for preparing multiple amphiphilic molecule layers, wherein the preparation device is provided with multiple micropores and a flow channel capable of allowing a solution to flow to the micropores, and the preparation device also includes an electrode layer, so that the solution flowing into the micropores can contact the electrode layer; S2 adding a first polar solution into the flow channel, so that the first polar solution enters at least one micropore and contacts the electrode layer; S3 sequentially adding a membrane solution and a second polar solution into the flow channel, so that the membrane solution forms a meniscus in the flow channel; S4 adding a second polar solution into the flow channel, so that the second polar solution pushes the membrane solution to move and flows through at least one micropore where the first polar solution contacts the electrode layer, and the amphiphilic molecules in the membrane solution form an amphiphilic molecule layer on the corresponding micropores. The method provided by the present invention is simple and safe to operate, and the selected preparation device has low production cost.
Description
分案申请Divisional application
本申请是基于申请号为CN2022103914733,申请日为2022年4月14日,发明名称“一种两亲性分子层的制备方法及装置”的中国发明专利申请的分案申请。This application is a divisional application based on the Chinese invention patent application with application number CN2022103914733, application date April 14, 2022, and invention name “A method and device for preparing an amphiphilic molecular layer”.
技术领域Technical Field
本发明涉及两亲性分子膜领域,具体涉及一种用于快速形成多个两亲性分子层的制备方法以及制备装置。The invention relates to the field of amphiphilic molecular films, and in particular to a preparation method and a preparation device for rapidly forming a plurality of amphiphilic molecular layers.
背景技术Background Art
纳米孔蛋白需要在一个磷脂或是高分子形成的薄膜,如两亲性分子层(也即两亲性分子膜)上实现稳定得嵌入才可以使待检测的DNA序列通过,以达到检测DNA序列的目的。然而,目前的一些用于制备两亲性分子层的制备方法(即成膜方法)和装置在应用上仍存在一些问题。Nanopore proteins need to be stably embedded in a thin film formed of phospholipids or polymers, such as an amphiphilic molecule layer (i.e., an amphiphilic molecule membrane), in order to allow the DNA sequence to pass through, so as to achieve the purpose of detecting the DNA sequence. However, some current preparation methods (i.e., film-forming methods) and devices for preparing amphiphilic molecule layers still have some problems in application.
现有的成膜方法主要有折叠双层形成法(Montal&Mueller的方法),浸尖法,涂布法,膜片钳法和油包水微滴界面法等等。以上方法如折叠双层法、浸尖法、涂布双层法等,往往初次所形成的膜较厚,需要进行薄化处理,例如通过有机溶剂挥发,或通过物理涂抹铺展,或通过空气气压挤压等。薄化处理对于膜厚的控制十分重要,但是操作过程复杂,且薄化步骤难以控制(例如,难以保证物理涂抹过程中能够均匀铺展)。同时,现有的成膜方法通常都涉及到对制备装置的预处理,如氟等离子体处理,硅烷化处理等等,这些预处理操作都需要用的高危化学品,并需要在建设成本高昂,维护费用高昂的实验室内进行。对操作人员的生命安全和周围环境存在潜在威胁。此外,预处理还需要对所使用到的涂料用量进行精确计算,涂料过多过少都会影响试验效果。而两亲性分子膜的制备装置通常都是小型芯片,其内部结构(如微孔等)尺寸微小,因此所选的涂料用量也非常少,在微小的结构上涂抹极少量的涂料在操作上并不简单,因此,在涂抹过程中也难以避免出现涂抹过多、过少的问题。The existing film forming methods mainly include folding double layer formation method (Montal & Mueller's method), tip dipping method, coating method, patch clamp method and oil-in-water droplet interface method, etc. The above methods such as folding double layer method, tip dipping method, coating double layer method, etc. often form thick films for the first time, and need to be thinned, such as by volatilization of organic solvents, or by physical spreading, or by air pressure extrusion, etc. Thinning treatment is very important for controlling film thickness, but the operation process is complicated, and the thinning step is difficult to control (for example, it is difficult to ensure uniform spreading during physical spreading). At the same time, the existing film forming methods usually involve pretreatment of the preparation device, such as fluorine plasma treatment, silanization treatment, etc. These pretreatment operations require the use of high-risk chemicals and need to be carried out in laboratories with high construction costs and high maintenance costs. There is a potential threat to the life safety of operators and the surrounding environment. In addition, the pretreatment also requires accurate calculation of the amount of coating used. Too much or too little coating will affect the test results. The preparation devices of amphiphilic molecular membranes are usually small chips, and their internal structures (such as micropores) are tiny in size, so the amount of paint selected is also very small. It is not easy to apply a very small amount of paint on a tiny structure. Therefore, it is difficult to avoid the problem of over- or under-application during the coating process.
例如,如申请号为201480056839.5的中国发明专利,该发明公开了一种用于生物芯片,且该发明还公开了该生物芯片的成膜方法,成膜方法包括步骤:将包含脂质分子(也即两亲性分子)的液体加入芯片表面,然后通过气泡隔开所述液体,使得脂质分子分布在芯片表面上,并且通过气泡使得脂质变薄。但是气泡生成往往需要手动操作控制(如通过移液枪制备出气泡),这个过程难以进行自动化控制,因为手动操作难以控制气泡的大小,且难以保证气泡的形态稳定,因此该方法的重复性也较差。并且也该方法也需要进行预处理。For example, the Chinese invention patent with application number 201480056839.5 discloses a biochip, and the invention also discloses a film-forming method for the biochip, which includes the steps of: adding a liquid containing lipid molecules (i.e., amphiphilic molecules) to the surface of the chip, and then separating the liquid with bubbles so that the lipid molecules are distributed on the surface of the chip, and the bubbles make the lipids thinner. However, bubble generation often requires manual operation control (such as preparing bubbles with a pipette), and this process is difficult to automate because it is difficult to control the size of the bubbles manually and it is difficult to ensure the stability of the bubble shape, so the repeatability of this method is also poor. And this method also requires pretreatment.
再例如,申请号为CN200880126160.3的中国发明,该发明公开了一种形成分隔两个体积的水溶液的层的方法,该方法通过使包含两亲性分子的水溶液流过主体以覆盖凹槽(也即微孔),使得水溶液可以跨越凹槽形成两亲性分子,虽然使得水溶液流过凹槽以形成两亲性分子这一技术容易实现,但是所制备的膜较厚,需要后续进行薄化处理,且该方法也涉及到预处理步骤。For another example, the Chinese invention with application number CN200880126160.3 discloses a method for forming a layer of aqueous solution separating two volumes. The method allows an aqueous solution containing amphiphilic molecules to flow through a main body to cover the grooves (i.e., micropores), so that the aqueous solution can cross the grooves to form amphiphilic molecules. Although the technology of allowing the aqueous solution to flow through the grooves to form amphiphilic molecules is easy to implement, the prepared membrane is relatively thick and requires subsequent thinning treatment, and the method also involves a pretreatment step.
发明内容Summary of the invention
为了部分地解决或部分缓解上述技术问题,本发明第一方面在于,提出了一种两亲性分子层的制备方法,一种两亲性分子层的制备方法,包括以下步骤:In order to partially solve or partially alleviate the above technical problems, the first aspect of the present invention is to propose a method for preparing an amphiphilic molecule layer, the method comprising the following steps:
S1提供用于制备多个两亲性分子层的制备装置,所述制备装置内设有多个微孔,以及能够使得溶液流向所述微孔的流道,所述制备装置内还包括电极层,使得流向所述微孔内的溶液可以与所述电极层相接触,其中,所述流道的横截面呈方形或类方形设置;S1 provides a preparation device for preparing multiple amphiphilic molecule layers, wherein the preparation device is provided with multiple micropores and flow channels that enable solutions to flow into the micropores, and the preparation device also includes an electrode layer so that the solutions flowing into the micropores can contact the electrode layer, wherein the cross section of the flow channel is square or quasi-square;
S2向所述流道内加入第一极性溶液,使得所述第一极性溶液进入至少一个所述微孔,并与所述电极层相接触;S2: adding a first polar solution into the flow channel, so that the first polar solution enters at least one of the micropores and contacts the electrode layer;
S3依次向所述流道内加入膜溶液和第二极性溶液,使得所述膜溶液在所述流道内形成弯月面;S3 sequentially adding a membrane solution and a second polar solution into the flow channel, so that the membrane solution forms a meniscus in the flow channel;
S4基于预设的注入速度向所述流道内加入所述第二极性溶液,使得所述第二极性溶液推动所述膜溶液移动并流经所述第一极性溶液与所述电极层相接触的至少一个微孔,所述膜溶液中的两亲性分子在相应的所述微孔上形成两亲性分子层;S4: adding the second polar solution into the flow channel based on a preset injection speed, so that the second polar solution pushes the membrane solution to move and flow through at least one micropore where the first polar solution contacts the electrode layer, and the amphiphilic molecules in the membrane solution form an amphiphilic molecule layer on the corresponding micropore;
其中,所述流道内表面的接触角为大约65°-大约120°。Wherein, the contact angle of the inner surface of the flow channel is about 65°-about 120°.
在一些实施例中,在所述S2之前,还包括步骤:对至少一个所述微孔进行润湿处理;In some embodiments, before S2, the method further includes: performing a wetting treatment on at least one of the micropores;
在一些实施例中,在所述S2中包括步骤:向所述流道内加入第一极性溶液之后,对所述制备装置进行超声处理。In some embodiments, S2 includes the step of: after adding the first polar solution into the flow channel, ultrasonically treating the preparation device.
在一些实施例中,所述润湿处理包括:电润湿处理。In some embodiments, the wetting process includes: an electrowetting process.
在一些实施例中,所述润湿处理包括:液体润湿处理。In some embodiments, the wetting treatment includes: liquid wetting treatment.
在一些实施例中,所述膜溶液包括:非极性溶液,以及两亲性分子。In some embodiments, the membrane solution includes: a non-polar solution, and amphiphilic molecules.
在一些实施例中,所述两亲性分子可选地包括:磷脂,或高分子,或磷脂和高分子的混合物。In some embodiments, the amphiphilic molecule optionally includes: phospholipids, or polymers, or a mixture of phospholipids and polymers.
在一些实施例中,所述非极性溶液可选地包括:烷烃类有机溶剂。In some embodiments, the non-polar solution optionally includes: an alkane organic solvent.
在一些实施例中,所述第一极性溶液包括:电解质,和/或聚电解质。In some embodiments, the first polar solution includes: an electrolyte, and/or a polyelectrolyte.
在一些实施例中,所述第一极性溶液包括:氧化还原对,和/或可以被部分氧化或还原以提供氧化还原对的氧化还原对的组合。In some embodiments, the first polar solution includes: a redox pair, and/or a combination of redox pairs that can be partially oxidized or reduced to provide a redox pair.
在一些实施例中,所述第一极性溶液包括:交联的琼脂糖凝胶,和/或交联的海藻酸钠凝胶。In some embodiments, the first polar solution includes: cross-linked agarose gel, and/or cross-linked sodium alginate gel.
在一些实施例中,所述第一极性溶液包括:用于调节pH的缓冲剂。In some embodiments, the first polar solution includes: a buffer for adjusting pH.
在一些实施例中,所述第二极性溶液包括:电解质,和/或聚电解质。In some embodiments, the second polar solution includes: an electrolyte, and/or a polyelectrolyte.
在一些实施例中,所述第二极性溶液包括:氧化还原对,和/或可以被部分氧化或还原以提供氧化还原对的氧化还原对的组合。In some embodiments, the second polar solution includes: a redox pair, and/or a combination of redox pairs that can be partially oxidized or reduced to provide a redox pair.
在一些实施例中,所述第二极性溶液包括:交联的琼脂糖凝胶,和/或交联的海藻酸钠凝胶。In some embodiments, the second polar solution includes: cross-linked agarose gel, and/or cross-linked sodium alginate gel.
在一些实施例中,所述第二极性溶液包括:用于调节pH的缓冲剂。In some embodiments, the second polar solution includes: a buffer for adjusting pH.
在一些实施例中,所述制备装置上还设有公用电极,所述公用电极与所述第二极性溶液相接触,相应地,所述方法还包括步骤:In some embodiments, the preparation device is further provided with a common electrode, and the common electrode is in contact with the second polar solution. Accordingly, the method further comprises the steps of:
通过所述电极层和所述公用电极向所述第一极性溶液和第二极性溶液通电,将纳米孔蛋白插入所述两亲性分子层中。Electricity is supplied to the first polar solution and the second polar solution through the electrode layer and the common electrode to insert the nanopore protein into the amphiphilic molecule layer.
在一些实施例中,在步骤S 3中,所述第二极性溶液的注入速度为大约10μL/min到大约50μL/min;In some embodiments, in step S3, the injection rate of the second polar solution is about 10 μL/min to about 50 μL/min;
在一些实施例中,在步骤S4中,所述第二极性溶液的注入速度为大约200μL/min到大约500μL/min。In some embodiments, in step S4, the injection rate of the second polar solution is about 200 μL/min to about 500 μL/min.
在一些实施例中,所述流道的内表面材料为聚甲醛。In some embodiments, the inner surface material of the flow channel is polyoxymethylene.
本发明第二方面在于,还提供了一种两亲性分子层的制备装置,所述制备装置内设置有多个微孔,以及能够使得溶液流向所述微孔内的流道,所述装置内还设置有电极层,使得流向所述微孔内的溶液能够与所述电极层相接触,其中,所述流道的横截面呈方形或类方形设置,所述流道的内表面材料可选地为聚甲醛。The second aspect of the present invention is to provide a device for preparing an amphiphilic molecular layer, wherein the device is provided with a plurality of micropores and a flow channel that enables the solution to flow into the micropores. The device is also provided with an electrode layer so that the solution flowing into the micropores can contact the electrode layer, wherein the cross-section of the flow channel is square or quasi-square, and the inner surface material of the flow channel can optionally be polyformaldehyde.
在一些实施例中,相邻所述微孔的间距大于大约0.4mm。In some embodiments, the spacing between adjacent microholes is greater than about 0.4 mm.
有益技术效果:Beneficial technical effects:
本发明提供了一种用于快速制备多个两亲性分子层(即两亲性分子膜,也简称“膜”)的制备方法(也即成膜方法)与制备装置。与现有技术不同的是,本发明的制备方法提出了一种新的成膜方法,即使得膜溶液在流道内形成弯月面,并通过极性溶液推动弯月面,从而使得弯月面能够在流道内移动并经过微孔,然后在相应的微孔上形成两亲性分子层(膜)。The present invention provides a preparation method (i.e., film-forming method) and a preparation device for rapidly preparing multiple amphiphilic molecular layers (i.e., amphiphilic molecular membranes, also referred to as "membranes"). Different from the prior art, the preparation method of the present invention proposes a new film-forming method, that is, a membrane solution forms a meniscus in a flow channel, and the meniscus is pushed by a polar solution, so that the meniscus can move in the flow channel and pass through micropores, and then an amphiphilic molecular layer (membrane) is formed on the corresponding micropores.
具体地,本发明提出的制备装置选用了疏水性满足成膜条件的材料,即该制备装置内的流道内表面的材料的接触角为大约65°-120°,使得加入到流道内的膜溶液能够在流道内表面、极性溶液以及流道内的空气的共同作用下,形成弯月面。其中,流道的横截面优选地呈方形或类方形的设置,此时,流道对膜溶液(或者说膜溶液所形成的弯月面)的移动会产生一定的阻力,使得膜溶液在流道内的移动速度不会过快,且膜溶液上各个位置的移动速度相对均匀(或者说,各个位置的流动速度的差别对弯月面的稳定性影响不大),使得弯月面能够在移动过程中能够保持稳定的形态。Specifically, the preparation device proposed in the present invention uses a hydrophobic material that meets the film-forming conditions, that is, the contact angle of the material on the inner surface of the flow channel in the preparation device is about 65°-120°, so that the membrane solution added to the flow channel can form a meniscus under the joint action of the inner surface of the flow channel, the polar solution and the air in the flow channel. Among them, the cross-section of the flow channel is preferably square or quasi-square. At this time, the flow channel will produce a certain resistance to the movement of the membrane solution (or the meniscus formed by the membrane solution), so that the movement speed of the membrane solution in the flow channel will not be too fast, and the movement speed of each position on the membrane solution is relatively uniform (or the difference in flow speed at each position has little effect on the stability of the meniscus), so that the meniscus can maintain a stable shape during the movement.
通过极性溶液推动弯月面(膜溶液)在微孔处成膜的成膜方式,可以对膜溶液的移动速度进行较为精准的控制(例如,通过移液枪或注射泵等对极性溶液的注入速度进行控制,从而对膜溶液的移动速度进行控制),从而使得膜溶液在不同的微孔处停留时间相同或相近,避免膜溶液在部分微孔区域停留过久而形成厚的膜,或者在部分微孔区域移动过快而没有成功形成膜。因此,本发明能够通过对膜溶液的移动速度进行较为精准的控制,从而高效、直接制成厚度适宜(或膜厚符合使用要求)的两亲性分子层,而无需在成膜后对膜进行薄化处理(如高压击穿,多次成膜)。换句话说,本发明的成膜方法可以一次成膜。By using a polar solution to push the meniscus (membrane solution) to form a film at the micropores, the moving speed of the membrane solution can be controlled more accurately (for example, the injection speed of the polar solution is controlled by a pipette gun or a syringe pump, so as to control the moving speed of the membrane solution), so that the membrane solution stays at different micropores for the same or similar time, avoiding the membrane solution staying in some micropore areas for too long to form a thick film, or moving too fast in some micropore areas and failing to successfully form a film. Therefore, the present invention can efficiently and directly form an amphiphilic molecular layer with a suitable thickness (or a film thickness that meets the use requirements) by more accurately controlling the moving speed of the membrane solution, without the need to thin the film after film formation (such as high-voltage breakdown, multiple film formation). In other words, the film forming method of the present invention can form a film in one time.
因此,在实际应用场景中,当膜溶液的浓度、移动速度等参数选定后(如通过预实验,或通过工作人员的操作经验确定),可以基于相同的实验条件和参数进行多次实验,且多次实验所得结果(如成膜情况)差别很小,也即是本方法的重复性较好。换句话说,本发明所提供的方法可以避免或减少工作人员的手动操作对实验操作的影响,以避免或减少操作过程中的不可控因素(即本方法可控性更好),从而具有较好的可重复性。Therefore, in actual application scenarios, after the concentration of the membrane solution, the moving speed and other parameters are selected (such as through preliminary experiments, or determined by the operating experience of the staff), multiple experiments can be performed based on the same experimental conditions and parameters, and the results obtained from multiple experiments (such as film formation) are very different, that is, the repeatability of this method is good. In other words, the method provided by the present invention can avoid or reduce the impact of the manual operation of the staff on the experimental operation, so as to avoid or reduce the uncontrollable factors in the operation process (that is, the controllability of this method is better), so as to have good repeatability.
并且,本发明提出的成膜方法无需进行预处理,成膜方法更加简单,且操作过程中对工作人员的安全性更有保障(不涉及到危险物品的操作与使用)。Furthermore, the film forming method proposed in the present invention does not require pretreatment, the film forming method is simpler, and the safety of the workers during the operation is better guaranteed (it does not involve the operation and use of dangerous goods).
进一步地,对极性溶液的注入速度的控制可以通过注射泵来实现,且注射泵可以通过电子设备(如计算机等)进行自动化控制(即本发明所提出的成膜方法可以实现自动化控制),从而可以进一步地减少工作人员的手动操作步骤,相应地也避免了工作人员手动操作可能造成的误差,以进一步地保证了成膜的稳定性与均一性。Furthermore, the injection speed of the polar solution can be controlled by a syringe pump, and the syringe pump can be automatically controlled by an electronic device (such as a computer, etc.) (that is, the film formation method proposed in the present invention can be automatically controlled), thereby further reducing the manual operation steps of the staff, and correspondingly avoiding the errors that may be caused by manual operation of the staff, so as to further ensure the stability and uniformity of the film formation.
本发明所提供成膜方法(以及装置)能够应用于实验室中的多种检测需求(如适用于科研单位、商业检测公司等不同的应用场景),且由于本发明能够一次性形成多个膜,因此在实际使用过程中,能够更好的满足于商业性或市场上的检测需求(如人类基因组测序、病毒测序等),这一类检测的检测周期相对较长,所需的数据量大,此时,工作人员在长期操作过程中出现误操作的概率也会增加。而本申请所提供的方法可以与现有技术中的自动化控制相配合,从而进一步提高检测结果的准确性与可靠性。The film forming method (and device) provided by the present invention can be applied to various detection needs in the laboratory (such as different application scenarios applicable to scientific research units, commercial detection companies, etc.), and because the present invention can form multiple films at one time, it can better meet the commercial or market detection needs (such as human genome sequencing, virus sequencing, etc.) in actual use. The detection cycle of this type of detection is relatively long and the amount of data required is large. At this time, the probability of staff making misoperations during long-term operation will also increase. The method provided by the present application can be coordinated with the automated control in the prior art to further improve the accuracy and reliability of the test results.
在现有技术中,为了保证包含两亲性分子的溶液能够覆盖(或流经)全部或多个微孔,以形成多个两亲性分子层,本领域技术人员通常会选择加入较多的包含两亲性分子的溶液,以避免存在部分微孔无法形成两亲性分子层,因此所生成的膜也相对较厚。而针对这一技术问题,本领域技术人员通常考虑的是在膜形成后,如何对膜进行进一步处理(也即薄化处理)以使得膜变薄,例如需要高压击穿多次成膜。而与现有技术不同的是,本申请采用了不同的技术路线,提出了一种新的成膜方法,该方法能够一次成膜,在操作流程上也更为简单,且由于避免了预处理、薄化等耗时较长的操作,本发明方法的耗时更少,效率更高。In the prior art, in order to ensure that the solution containing amphiphilic molecules can cover (or flow through) all or multiple micropores to form multiple amphiphilic molecule layers, those skilled in the art usually choose to add more solutions containing amphiphilic molecules to avoid the existence of some micropores that cannot form amphiphilic molecule layers, so the generated film is also relatively thick. In response to this technical problem, those skilled in the art usually consider how to further process the film (i.e., thinning treatment) after the film is formed to make the film thinner, such as requiring high-voltage breakdown to form multiple films. Unlike the prior art, the present application adopts a different technical route and proposes a new film-forming method, which can form a film at one time and is simpler in the operating process. And because it avoids time-consuming operations such as pretreatment and thinning, the method of the present invention is less time-consuming and more efficient.
并且,基于现有的制备装置,本领域技术人员也难以想到本申请提出的成膜方法。首先,现有技术中的制备装置并没有提供弯月面的形成条件,同样地,现有技术的方法与装置也难以保证弯月面在流道内能够稳定地移动。并且,由于现有技术中的装置选用了与本申请不同的材料,且均需要对装置进行预处理,而预处理可能会使得装置内的流道更加难以形成弯月面。Moreover, based on the existing preparation devices, it is difficult for those skilled in the art to think of the film forming method proposed in this application. First, the preparation device in the prior art does not provide the conditions for the formation of a meniscus. Similarly, the methods and devices in the prior art are also difficult to ensure that the meniscus can move stably in the flow channel. Moreover, since the devices in the prior art use different materials from those in this application, and both require pretreatment of the devices, the pretreatment may make it more difficult to form a meniscus in the flow channel in the device.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作一简单地介绍。在所有附图中,类似的元件或部分一般由类似的附图标记标识。附图中,各元件或部分并不一定按照实际的比例绘制。显而易见地,下面描述中的附图是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其它的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings required for use in the embodiments or the prior art descriptions are briefly introduced below. In all the drawings, similar elements or parts are generally identified by similar reference numerals. In the drawings, each element or part is not necessarily drawn according to the actual scale. Obviously, the drawings described below are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained based on these drawings without paying creative labor.
图1a是本发明一示例性实施例中的制备装置的横截面结构示意图;FIG. 1a is a schematic cross-sectional view of a preparation device in an exemplary embodiment of the present invention;
图1b是本发明一示例性实施例中制备装置的流道的横截面可选结构示意图;FIG1b is a schematic diagram of an optional cross-sectional structure of a flow channel of a preparation device in an exemplary embodiment of the present invention;
图1c是本发明另一示例性实施例中制备装置的横截面结构示意图;FIG1c is a schematic cross-sectional view of a preparation device in another exemplary embodiment of the present invention;
图2是本发明又一示例性实施例中的制备装置的结构示意图;FIG2 is a schematic structural diagram of a preparation device in another exemplary embodiment of the present invention;
图3是本发明一示例性实施例中的制备装置的结构示意图;FIG3 is a schematic structural diagram of a preparation device in an exemplary embodiment of the present invention;
图4a是本发明一示例性实施例中制备装置的微孔处第一极性液体的第一状态示意图;FIG4a is a schematic diagram of a first state of a first polar liquid at a micropore of a preparation device in an exemplary embodiment of the present invention;
图4b是本发明一示例性实施例中制备装置的微孔处第一极性液体的第二状态示意图;FIG4 b is a schematic diagram of a second state of the first polar liquid at the micropores of the preparation device in an exemplary embodiment of the present invention;
图4c是本发明一示例性实施例中制备装置的微孔处第一极性液体的第三状态示意图;FIG4c is a schematic diagram of a third state of the first polar liquid at the micropores of the preparation device in an exemplary embodiment of the present invention;
图5是本发明一示例性实施例中的制备方法的流程示意图;FIG5 is a schematic flow diagram of a preparation method in an exemplary embodiment of the present invention;
图6是两亲性分子的结构示意图;FIG6 is a schematic diagram of the structure of an amphiphilic molecule;
图7a是弯月面在流道内的第一结构示意图;FIG7a is a schematic diagram of a first structure of a meniscus in a flow channel;
图7b是弯月面在流道内的第二结构示意图;FIG7 b is a schematic diagram of a second structure of a meniscus in a flow channel;
图8是微孔处形成的两亲性分子膜的结构示意图;FIG8 is a schematic diagram of the structure of an amphiphilic molecular membrane formed at a micropore;
图9a示出了接触角与固、液、气之间的关系;Figure 9a shows the relationship between the contact angle and solid, liquid, and gas;
图9b示出了液体润湿毛细管的过程;FIG9 b shows the process of liquid wetting the capillary;
图10示出了微孔处形成的不同厚度的膜的结构示意图;FIG10 is a schematic diagram showing the structure of membranes of different thicknesses formed at micropores;
图11a示出了本发明一示例性实施例中的制备装置内的流道的结构示意图;FIG. 11a shows a schematic structural diagram of a flow channel in a preparation device in an exemplary embodiment of the present invention;
图11b示出了本发明一示例性实施例中的弯月面在移动过程中的形状变化示意图。FIG. 11 b is a schematic diagram showing the shape change of the meniscus during the movement in an exemplary embodiment of the present invention.
1为第一结构层,11为流道,12为第一开口,13为第二开口,14为电极插入口,15为第一流道,16为第三开口,2为第二结构层,21为微孔,3为第三结构层,31为电极层,32为电极凸块,4为弯月面,5为两亲性分子,51为疏水端,52为亲水端,6为第一极性溶液,7为第二极性溶液,8为空气,L为溶液,G为气体,S为固体。1 is the first structural layer, 11 is the flow channel, 12 is the first opening, 13 is the second opening, 14 is the electrode insertion port, 15 is the first flow channel, 16 is the third opening, 2 is the second structural layer, 21 is the micropore, 3 is the third structural layer, 31 is the electrode layer, 32 is the electrode protrusion, 4 is the meniscus, 5 is the amphiphilic molecule, 51 is the hydrophobic end, 52 is the hydrophilic end, 6 is the first polar solution, 7 is the second polar solution, 8 is air, L is the solution, G is the gas, and S is the solid.
具体实施方式DETAILED DESCRIPTION
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述。显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
本文中,使用用于表示元件的诸如“模块”、“部件”或“单元”的后缀仅为了有利于本发明的说明,其本身没有特定的意义。因此,“模块”、“部件”或“单元”可以混合地使用。Herein, suffixes such as "module", "component" or "unit" used to represent elements are only used to facilitate the description of the present invention, and have no specific meanings by themselves. Therefore, "module", "component" or "unit" can be used mixedly.
本文中,术语“上”、“下”、“内”、“外”“前端”、“后端”、“两端”、“一端”、“另一端”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性。In this document, the terms "upper", "lower", "inner", "outer", "front end", "rear end", "two ends", "one end", "the other end" and the like indicate positions or positional relationships based on the positions or positional relationships shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the devices or elements referred to must have a specific orientation, be constructed and operate in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, the terms "first" and "second" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance.
本文中,除非另有明确的规定和限定,术语“安装”、“设置有”、“连接”、“相连”等,应做广义理解,例如“相连”,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是无线连接,也可以是无线通信连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。In this document, unless otherwise clearly specified and limited, the terms "installed", "provided with", "connected", "connected", etc. should be understood in a broad sense. For example, "connected" can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a wireless connection or a wireless communication connection; it can be a direct connection or an indirect connection through an intermediate medium, and it can be the internal connection of two elements. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
本文中,“两亲性”分子是指同时具有亲水性和亲脂性这两种性质的化合物,其具有亲水的头部和疏水的尾部。亲水的头部一般由极性基团组成,例如胆碱、铵盐;疏水的尾部一般由长的脂肪链组成。在本文,“两亲”和“两亲性”被同义地使用。两亲性分子可以是脂质分子。典型的两亲性分子膜(或两亲性分子层,也简称“膜”)可以是脂质双层,其为两个相对的脂质单层形成的双层,两个脂质单层经过自组装排布,使得疏水的尾部相互面对以形成疏水性内部,而亲水的头部分别朝向外部(每一侧都为极性亲水环境)。形成脂质双层的脂质可以包括任何合适的脂质,例如1,2-二植烷酰-sn-甘油-3-磷脂胆碱、二植酰磷脂酰胆碱(DPhPC)。两亲性分子可以被化学修饰或功能化以促进多核苷酸的偶联。两亲性分子还可以是通过物理化学方法合成的高分子材料,例如ABA三嵌段共聚物(PMOXA-PDMS-PMOXA二甲基恶唑啉-聚二甲基硅氧烷-二甲基恶唑啉)。两亲性分子可以是混合物。Herein, "amphiphilic" molecules refer to compounds having both hydrophilic and lipophilic properties, which have a hydrophilic head and a hydrophobic tail. The hydrophilic head is generally composed of polar groups, such as choline, ammonium salts; the hydrophobic tail is generally composed of long fatty chains. Herein, "amphiphilic" and "amphiphilic" are used synonymously. Amphiphilic molecules can be lipid molecules. A typical amphiphilic molecular membrane (or amphiphilic molecular layer, also referred to as "membrane") can be a lipid bilayer, which is a bilayer formed by two opposing lipid monolayers, and the two lipid monolayers are arranged through self-assembly so that the hydrophobic tails face each other to form a hydrophobic interior, while the hydrophilic heads face the outside (each side is a polar hydrophilic environment). The lipids forming the lipid bilayer can include any suitable lipids, such as 1,2-diphytanoyl-sn-glycero-3-phosphatidylcholine, diphytylphosphatidylcholine (DPhPC). Amphiphilic molecules can be chemically modified or functionalized to promote the coupling of polynucleotides. The amphiphilic molecule may also be a polymer material synthesized by physical and chemical methods, such as ABA triblock copolymer (PMOXA-PDMS-PMOXA dimethyloxazoline-polydimethylsiloxane-dimethyloxazoline). The amphiphilic molecule may be a mixture.
本文中,“非极性溶剂”或“非极性溶液”是指不与水混溶的化合物或化合物混合物。非极性溶剂可以是油,更具体地,可以是纯链烷烃,例如正十六烷、正癸烷、正戊烷、正己烷、正庚烷、正辛烷、四氯化碳。其他类型的油也是可能的,例如,硅油。更具体地,油可以是甲基苯基硅油AR20、羟基封端聚二甲基硅氧烷PDMS-OH。Herein, "non-polar solvent" or "non-polar solution" refers to a compound or mixture of compounds that is immiscible with water. The non-polar solvent can be an oil, more specifically, a pure paraffin, such as n-hexadecane, n-decane, n-pentane, n-hexane, n-heptane, n-octane, carbon tetrachloride. Other types of oils are also possible, for example, silicone oil. More specifically, the oil can be methylphenyl silicone oil AR20, hydroxyl-terminated polydimethylsiloxane PDMS-OH.
本文中,“极性水溶液”或“极性溶液”是指容易与水和其他极性溶剂混溶的含有水的水溶液。极性水溶液可以包括一种或多种溶质。例如,可以包括能够调节极性水溶液的pH的缓冲剂。缓冲剂可以包括任何合适的缓冲剂,例如磷酸盐缓冲剂(PBS)、4-双-2-乙烷磺酸缓冲剂PIPES、N-2-羟乙基哌嗪-N’-乙烷磺酸缓冲剂(HEPES)。极性水溶液还可以是电解质或聚电解质,以有效提升离子交换寿命。极性水溶液还可以包含氧化还原对或可以被部分氧化或还原以提供氧化还原对的氧化还原对的组合,例如铁/压铁氰化物。极性水溶液也可以是交联的琼脂糖凝胶和海藻酸钠凝胶。Herein, "polar aqueous solution" or "polar solution" refers to an aqueous solution containing water that is easily miscible with water and other polar solvents. The polar aqueous solution may include one or more solutes. For example, a buffer capable of adjusting the pH of the polar aqueous solution may be included. The buffer may include any suitable buffer, such as phosphate buffer (PBS), 4-bis-2-ethanesulfonic acid buffer PIPES, N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid buffer (HEPES). The polar aqueous solution may also be an electrolyte or a polyelectrolyte to effectively enhance the ion exchange life. The polar aqueous solution may also include a redox pair or a combination of redox pairs that may be partially oxidized or reduced to provide a redox pair, such as iron/ferrocyanide. The polar aqueous solution may also be a cross-linked agarose gel and sodium alginate gel.
本文中,“自组装”是指分子在合适的环境中自发组装或组织,以形成高度有序的结构如两亲性分子膜的能力。As used herein, "self-assembly" refers to the ability of molecules to spontaneously assemble or organize in a suitable environment to form highly ordered structures such as amphiphilic molecular films.
本文中,“方形”包括邻边夹角呈大约90°或接近90°的多边形,例如,方形为四边形,如正方形,或矩形(如图1b中的a所示)等。当然,本文中的“方形”并不一定需要设置为标准的正方形或矩形或其他多边形,例如,方形中的“四边形”的对边可以呈平行设置,也可以设置为不平行,相应地,“四边形”的邻边可以呈相互垂直的设置,也可以设置为不垂直。“类方形”包括在邻边夹角处作了倒角处理的方形,或者邻边通过圆弧连接的方形,例如,类四边形,如类矩形(如图1b中的b所示,矩形的顶角替换为圆弧结构)、类正方形(如将正方形的顶角替换为圆弧结构)等。例如,本文中,“流道的横截面呈方形或类方形”指的是流道的横截面可以设置为矩形,或正方形,或类矩形,或类正方形等。为了避免流道内表面在加工过程中出现毛刺等缺陷,优选地,将流道的横截面设置为类方形,如类矩形,或类正方形等。Herein, "square" includes polygons whose adjacent sides have an angle of about 90° or close to 90°, for example, the square is a quadrilateral, such as a square, or a rectangle (as shown in a in Figure 1b), etc. Of course, the "square" in this article does not necessarily need to be set as a standard square, rectangle or other polygon. For example, the opposite sides of the "quadrilateral" in the square can be set in parallel or non-parallel, and correspondingly, the adjacent sides of the "quadrilateral" can be set perpendicular to each other or non-perpendicular. "Quasi-square" includes a square with chamfers at the adjacent side angles, or a square with adjacent sides connected by arcs, for example, a quasi-quadrilateral, such as a quasi-rectangle (as shown in b in Figure 1b, the top corners of the rectangle are replaced with arc structures), a quasi-square (such as replacing the top corners of the square with arc structures), etc. For example, here, "the cross-section of the flow channel is square or quasi-square" means that the cross-section of the flow channel can be set as a rectangle, or a square, or a quasi-rectangle, or a quasi-square, etc. In order to avoid defects such as burrs on the inner surface of the flow channel during processing, preferably, the cross-section of the flow channel is set to be square-like, such as rectangular, square, etc.
本文中,术语“约”、“大约”,典型地表示为所述值的+/-5%,更典型的是所述值的+/-4%,更典型的是所述值的+/-3%,更典型的是所述值的+/-2%,甚至更典型的是所述值的+/-1%,甚至更典型的是所述值的+/-0.5%,或者表示的是本领域技术人员理解的包括了本领域惯常的误差范围的取值。Herein, the terms "about" and "approximately" are typically expressed as +/-5% of the value, more typically +/-4% of the value, more typically +/-3% of the value, more typically +/-2% of the value, even more typically +/-1% of the value, even more typically +/-0.5% of the value, or indicate a value that is understood by those skilled in the art to include the customary range of error in the art.
本文中,某些实施方式可能以一种处于某个范围的格式公开。应该理解,这种“处于某个范围”的描述仅仅是为了方便和简洁,且不应该被解释为对所公开范围的僵化限制。因此,范围的描述应该被认为是已经具体地公开了所有可能的子范围以及在此范围内的独立数字值,例如接触角在“大约65度到大约120度”可以理解为已经公开了如下范围:接触角在大约65-95度、95-105度、105-120度等等,还公开了在此范围内的独立数字值,如65度、69度、75度、80度、90度、100度、110度、120度。Herein, some embodiments may be disclosed in a format that is in a certain range. It should be understood that the description of this "being in a certain range" is only for convenience and brevity, and should not be interpreted as a rigid limitation to the disclosed range. Therefore, the description of the range should be considered to have specifically disclosed all possible sub-ranges and independent digital values within this range, such as the contact angle of "about 65 degrees to about 120 degrees" can be understood as having disclosed the following range: the contact angle is about 65-95 degrees, 95-105 degrees, 105-120 degrees, etc., and also discloses independent digital values within this range, such as 65 degrees, 69 degrees, 75 degrees, 80 degrees, 90 degrees, 100 degrees, 110 degrees, 120 degrees.
实施例一Embodiment 1
本发明第一方面在于,提供了一种快速形成两亲性分子膜(两亲性分子层)的制备装置,参见图1a-图4,所述制备装置内设有多个微孔21,以及能够使得溶液流向所述微孔21内的流道11,所述制备装置还包括:电极层31,使得流向所述微孔21内的溶液(如极性溶液,也即电解液)可以与所述电极层31相接触,其中,所述流道的横截面优选地呈方形或类方形设置。当然,流道的横截面只要能够使得膜溶液能够形成弯月面并以弯月面形式进行移动,均属于本发明的保护范围内。其中,所述微孔为膜溶液形成两亲性分子层(两亲性分子膜,也简称“膜”)提供了成长平台。The first aspect of the present invention is to provide a preparation device for quickly forming an amphiphilic molecular membrane (amphiphilic molecular layer), referring to Figures 1a to 4, wherein the preparation device is provided with a plurality of micropores 21, and a flow channel 11 that enables the solution to flow into the micropores 21, and the preparation device also includes: an electrode layer 31, so that the solution (such as a polar solution, i.e., an electrolyte) flowing into the micropores 21 can contact the electrode layer 31, wherein the cross-section of the flow channel is preferably square or quasi-square. Of course, as long as the cross-section of the flow channel enables the membrane solution to form a meniscus and move in the form of a meniscus, it belongs to the protection scope of the present invention. Among them, the micropores provide a growth platform for the membrane solution to form an amphiphilic molecular layer (amphiphilic molecular membrane, also referred to as "membrane").
在一些实施例中,流道内表面选用高分子材料加工而成,且流道内表面所选材料的接触角(即材料与纯水之间的接触角)在大约65度到大约120度。In some embodiments, the inner surface of the flow channel is made of a polymer material, and the contact angle of the material selected for the inner surface of the flow channel (ie, the contact angle between the material and pure water) is about 65 degrees to about 120 degrees.
优选地,在一些实施例中,流道内表面的接触角在大约75度到95度。Preferably, in some embodiments, the contact angle of the inner surface of the flow channel is about 75 degrees to 95 degrees.
优选地,在一些实施例中,流道内表面所选用的材料为聚甲醛(delrin)。Preferably, in some embodiments, the material selected for the inner surface of the flow channel is polyoxymethylene (delrin).
具体地,在一些实施例中,流道内表面以及微孔表面(微孔侧壁)所选用的材料为聚甲醛,使得加入流道内的膜溶液能够在流道内形成弯月面,且能够在微孔处形成两亲性分子层,因此,本实施例中的制备装置在使用时无需进行预处理。Specifically, in some embodiments, the material selected for the inner surface of the flow channel and the micropore surface (micropore side wall) is polyformaldehyde, so that the membrane solution added to the flow channel can form a meniscus in the flow channel and can form an amphiphilic molecular layer at the micropores. Therefore, the preparation device in this embodiment does not need to be pretreated when used.
优选地,在一些实施例中,制备装置所选用的材料为聚甲醛。Preferably, in some embodiments, the material selected for preparing the device is polyoxymethylene.
对于本领域技术人员来说,通过预实验选取适合的制备材料是能够实现的。具体地,可以通过接触角测试方法(如外形图像分析方法,或称重法)测试得到不同材料的接触角,以选用出适合的制备材料。具体地,当材料的接触角处于大约65°-120°时(当然,只要选出的材料所制备出的流道能够形成弯月面即可),则认为该材料制备得到的流道具备形成弯月面的能力。For those skilled in the art, it is possible to select suitable preparation materials through preliminary experiments. Specifically, the contact angles of different materials can be tested by contact angle testing methods (such as appearance image analysis methods, or weighing methods) to select suitable preparation materials. Specifically, when the contact angle of the material is about 65°-120° (of course, as long as the flow channel prepared by the selected material can form a meniscus), it is considered that the flow channel prepared by the material has the ability to form a meniscus.
进一步地,在一些实施例中,所述流道包括第一开口,用于向流道内加样(即添加液体,如膜溶液与极性溶液)。Furthermore, in some embodiments, the flow channel includes a first opening for adding a sample (ie, adding a liquid, such as a membrane solution and a polar solution) into the flow channel.
进一步地,在一些实施例中,所述流道还包括:第二开口,用于排出流道内的液体。Furthermore, in some embodiments, the flow channel further includes: a second opening for discharging the liquid in the flow channel.
进一步地,在一些实施例中,所述流道上还设有电极插入口,用于插入公用电极。Furthermore, in some embodiments, the flow channel is also provided with an electrode insertion port for inserting a common electrode.
具体地,在一些实施例中,参见图1,该装置包括:本体,本体上包括依次设置的第一结构层1、第二结构层2和第三结构层3,其中,第一结构层1上设有流道11,且所述流道11的一端设有第一开口12,用于加样,第二结构层2上间隔设有多个微孔21,所述第三结构层3上设有电极层(相当于第一电极);Specifically, in some embodiments, referring to FIG. 1 , the device includes: a body, the body includes a first structure layer 1, a second structure layer 2 and a third structure layer 3 arranged in sequence, wherein a flow channel 11 is provided on the first structure layer 1, and a first opening 12 is provided at one end of the flow channel 11 for adding samples, a plurality of micropores 21 are provided at intervals on the second structure layer 2, and an electrode layer (equivalent to the first electrode) is provided on the third structure layer 3;
当向流道内加入溶液(如第一极性溶液),且溶液流经至少一个微孔时,溶液置换至少一个微孔中的空气(例如,溶液可以充满至少一个微孔中,参见图4a,第一极性溶液6充满在微孔中),并与所述电极层相接触,使得溶液(如第一极性溶液)能够在电极作用下导电。When a solution (such as a first polar solution) is added to the flow channel and the solution flows through at least one micropore, the solution replaces the air in at least one micropore (for example, the solution can fill at least one micropore, see Figure 4a, the first polar solution 6 fills the micropore) and contacts the electrode layer, so that the solution (such as the first polar solution) can conduct electricity under the action of the electrode.
在一些实施例中,第二结构层通过键合,图形化交联的设备,或是AZ4620,su-8和电极层上一一对应的电极粘合在一起,上面的流道只设有(插入)一个公用电极。In some embodiments, the second structure layer is bonded together with corresponding electrodes on the electrode layer by bonding, patterned cross-linking equipment, or AZ4620, su-8, and the flow channel above is only provided with (inserted with) one common electrode.
由于流道内表面以及微孔的侧壁(即微孔内表面)所选用的材料具有一定的疏水性,因此如果没有预先对流道内表面以及微孔侧壁进行润湿处理,在一些实施例中,极性溶液可能无法顺利地进入微孔中,或者说在另一些实施例中,仅有部分极性溶液能够进入微孔内部,而不能充满微孔。Since the materials used for the inner surface of the flow channel and the side walls of the micropores (i.e., the inner surface of the micropores) have a certain degree of hydrophobicity, if the inner surface of the flow channel and the side walls of the micropores are not pre-wetted, in some embodiments, the polar solution may not be able to enter the micropores smoothly, or in other embodiments, only a portion of the polar solution can enter the interior of the micropores and cannot fill the micropores.
因此,在一些实施例中,首先加入的第一极性溶液可能无法完全充满所述微孔,例如,参见图4b,第一极性溶液6在微孔处形成悬挂于微孔的第一端的液滴,并使得所述第一极性溶液6形成的液滴与电极层31相互接触即可。Therefore, in some embodiments, the first polar solution added first may not be able to completely fill the micropores. For example, referring to FIG. 4b , the first polar solution 6 forms droplets suspended at the first end of the micropores, and the droplets formed by the first polar solution 6 are in contact with the electrode layer 31 .
进一步地,在一些实施例中,为了保证第一极性溶液6所形成液滴与电极层能够实现相互接触,在电极层31上还设有至少一个电极凸块32(如探针等),使得当第一极性溶液所形成的液滴体积较小时,也能与电极层相互接触。Furthermore, in some embodiments, in order to ensure that the droplets formed by the first polar solution 6 can contact the electrode layer, at least one electrode bump 32 (such as a probe, etc.) is provided on the electrode layer 31, so that when the volume of the droplets formed by the first polar solution is small, they can also contact the electrode layer.
进一步地,在一些实施例中,为了使得第一极性溶液所形成的液滴与电极层能够实现相互接触,还可以在微孔的侧壁22上设置用于导电的电极层31。进一步地,还可以在电极层31上设置电极凸块32。Furthermore, in some embodiments, in order to enable the droplets formed by the first polar solution to contact the electrode layer, an electrode layer 31 for conducting electricity may be provided on the sidewall 22 of the micropore. Furthermore, an electrode bump 32 may be provided on the electrode layer 31.
或者,在另一些实施例中,参见图4c,首先通入流道中的第一极性溶液仅在微孔的第一端形成一层较薄的溶液膜(层),此时,为了使得第一极性溶液能够与电极层相接触,同样可以在电极层上设置电极凸块32(如探针等),从而保证第一极性溶液能够与电极层实现相接触。Alternatively, in some other embodiments, referring to FIG. 4c, the first polar solution firstly introduced into the flow channel only forms a thin solution film (layer) at the first end of the micropore. At this time, in order to enable the first polar solution to contact the electrode layer, an electrode bump 32 (such as a probe, etc.) can also be provided on the electrode layer, thereby ensuring that the first polar solution can contact the electrode layer.
具体地,在一些实施例中,微孔的第一端(即上端,也即与流道相连通的一端)的内径大于微孔的第二端(即微孔的另一端)的内径大小。本实施例中,微孔呈上小下大的设计,从而能够在不影响微孔第一端的大小(微孔的第一端的内径大小与两亲性分子层的形成密切相关,因此,微孔的第一端的内径尺寸通常固定设置在大约100微米-200微米之间)的情况下,使得微孔内部有足够的空间来容纳极性溶液(如首先加入微孔内的第一极性溶液)。具体地,当弯月面流经微孔时,弯月面中的两亲性分子层形成于微孔最窄处,即两亲性分子在微孔的第一端处自组装形成两亲性分子层。Specifically, in some embodiments, the inner diameter of the first end of the micropore (i.e., the upper end, i.e., the end connected to the flow channel) is larger than the inner diameter of the second end of the micropore (i.e., the other end of the micropore). In this embodiment, the micropore is designed to be small at the top and large at the bottom, so that there is enough space inside the micropore to accommodate the polar solution (such as the first polar solution first added to the micropore) without affecting the size of the first end of the micropore (the inner diameter of the first end of the micropore is closely related to the formation of the amphiphilic molecule layer, so the inner diameter of the first end of the micropore is usually fixed between about 100 microns and 200 microns). Specifically, when the meniscus flows through the micropore, the amphiphilic molecule layer in the meniscus is formed at the narrowest part of the micropore, that is, the amphiphilic molecules self-assemble at the first end of the micropore to form an amphiphilic molecule layer.
例如,在一些实施例中,参见图1a和图4所示,微孔呈上小下大的喇叭状设置。For example, in some embodiments, referring to FIG. 1 a and FIG. 4 , the microholes are arranged in a trumpet shape that is small at the top and large at the bottom.
在另一些实施例中,微孔也可呈圆柱状设置(即上下端等大),或呈上大下小设置。当然,微孔也可以设置为其他形状,只要微孔的形状设置能够成功形成两亲性分子层,则均属于本发明的保护范围内。In other embodiments, the micropores may be arranged in a cylindrical shape (i.e., the upper and lower ends are equal in size), or arranged in a shape of being larger at the top and smaller at the bottom. Of course, the micropores may also be arranged in other shapes, as long as the shape of the micropores can successfully form an amphiphilic molecule layer, they are all within the scope of protection of the present invention.
进一步地,在一些实施例中,流道上还设有第二开口,用于排出流道内的液体。Furthermore, in some embodiments, the flow channel is provided with a second opening for discharging the liquid in the flow channel.
在一些实施例中,第二开口还可以用于插入第二电极(即公用电极),因此,在一些实施例中,可以不在流道上设置电极插入口,从而简化装置的结构。In some embodiments, the second opening may also be used to insert a second electrode (ie, a common electrode). Therefore, in some embodiments, an electrode insertion port may not be provided on the flow channel, thereby simplifying the structure of the device.
进一步地,在一些实施例中,参见图1a-图3,在流道上还设有电极插入口14,具体地,第二电极通过电极插入口14插入所述流道中。Furthermore, in some embodiments, referring to FIG. 1 a - FIG. 3 , an electrode insertion port 14 is further provided on the flow channel. Specifically, the second electrode is inserted into the flow channel through the electrode insertion port 14 .
进一步地,在一些实施例中,第二结构层上设有与第二电极相配合的配合部,当所述第二电极插入所述流道中时,第二电极的第一端(即插入端)与配合部相配合(如相互接触)。Furthermore, in some embodiments, a mating portion mating with the second electrode is provided on the second structural layer, and when the second electrode is inserted into the flow channel, the first end (ie, the insertion end) of the second electrode mating with the mating portion (eg, contacting each other).
进一步地,为了对第二电极起到固定作用,以提高制备装置在工作过程中的稳定性,在一些实施例中,配合部为凹槽(即在第二结构层的第一表面上设有凹槽),当所述第二电极与配合部相配合时,所述第二电极的第一端插入凹槽中。本实施例中,由于将第二电极插入了凹槽中进行固定,一方面便于第二电极的定位安装(避免第二电极在插入过程中发生偏移),同时使得第二电极在使用过程中不会发生水平方向上位移晃动,提高了第二电极的工作稳定性。Furthermore, in order to fix the second electrode and improve the stability of the preparation device during operation, in some embodiments, the matching portion is a groove (i.e., a groove is provided on the first surface of the second structural layer), and when the second electrode matches the matching portion, the first end of the second electrode is inserted into the groove. In this embodiment, since the second electrode is inserted into the groove for fixing, on the one hand, it is convenient to position and install the second electrode (avoiding the second electrode from being offset during the insertion process), and at the same time, the second electrode will not be displaced or shaken in the horizontal direction during use, thereby improving the working stability of the second electrode.
并且,本实施例中的第二电极(也即公共电极)可以设置为可拆卸状态,即可以由工作人员自行安装(插入)与取出,从而便于对第二电极进行更换与清洁。Furthermore, the second electrode (ie, the common electrode) in this embodiment can be set to be detachable, that is, it can be installed (inserted) and removed by the staff themselves, so that the second electrode can be easily replaced and cleaned.
可以理解的是,第一、二电极的极性相反,例如,在一些实施例中,第一电极为正极,第二电极为负极。再例如,在另一些实施例中,第一电极为负极,第二电极为正极。It is understandable that the polarities of the first and second electrodes are opposite, for example, in some embodiments, the first electrode is a positive electrode and the second electrode is a negative electrode. For another example, in other embodiments, the first electrode is a negative electrode and the second electrode is a positive electrode.
优选地,在一些实施例中,第三结构层为ASIC电路层,电极层部分为TSV通孔电极,所选电极材料为纯金。含有多个微孔(如8*32=256个微孔阵列)的芯片(即第二结构层)通过热压键合,永久胶键合机,光刻胶AZ4620或者su-8与第三结构层进行键合。公用电极优选地采用镀金的铜柱插入芯片的凹槽中。流道的第一开口(即进样口)、第二开口(即出样口)采用微流控专用管路进行加样(即加入相应的液体,如极性溶液或膜溶液)、出样,使用注射泵(如往复式注射泵)控制极性溶液的流速以控制膜溶液的移动速度。Preferably, in some embodiments, the third structural layer is an ASIC circuit layer, the electrode layer part is a TSV through-hole electrode, and the selected electrode material is pure gold. A chip (i.e., the second structural layer) containing a plurality of micropores (e.g., an array of 8*32=256 micropores) is bonded to the third structural layer by hot pressing bonding, a permanent adhesive bonding machine, and photoresist AZ4620 or su-8. The common electrode is preferably a gold-plated copper column inserted into the groove of the chip. The first opening (i.e., the sample inlet) and the second opening (i.e., the sample outlet) of the flow channel are used for adding samples (i.e., adding corresponding liquids, such as polar solutions or membrane solutions) and discharging samples using a microfluidic dedicated pipeline, and a syringe pump (e.g., a reciprocating syringe pump) is used to control the flow rate of the polar solution to control the movement speed of the membrane solution.
优选地,在一些实施例中,所选用的往复式注射泵型号为harvard apparatus4400。Preferably, in some embodiments, the selected reciprocating syringe pump model is Harvard Apparatus 4400.
进一步地,在一些实施例中,微孔的孔径在大约100微米到大约200微米之间,例如,微孔的第一端的内径大小在大约100微米到200微米。Further, in some embodiments, the pore size of the micropore is between about 100 microns and about 200 microns, for example, the inner diameter of the first end of the micropore is between about 100 microns and about 200 microns.
优选地,在一些实施例中,微孔的孔径在大约150微米到200微米之间,例如,微孔的第一端的内径大小在大约150微米到200微米。Preferably, in some embodiments, the pore size of the micropore is between about 150 microns and 200 microns, for example, the inner diameter of the first end of the micropore is between about 150 microns and 200 microns.
优选地,在一些实施例中,为了便于加工,参见图2,第二结构层上的微孔呈多阵列设置,例如呈2*8排布,或呈8*32排布。Preferably, in some embodiments, in order to facilitate processing, referring to FIG. 2 , the microholes on the second structural layer are arranged in multiple arrays, for example, in a 2*8 arrangement, or in an 8*32 arrangement.
优选地,在一些实施例中,为了便于加工,参见图3,制备装置的长度L1为大约40mm到51mm之间,制备装置的宽度L2为大约16mm到27mm之间,流道内部的最大宽度L3为大约4.0-12.0mm之间,流道第一、二开口处的宽度(流道内部的最小宽度)L4为大约0.3mm-0.8mm之间,微孔阵列的长度L5为大约10.5-20.5mm之间。Preferably, in some embodiments, for ease of processing, referring to FIG. 3 , the length L1 of the preparation device is approximately between 40 mm and 51 mm, the width L2 of the preparation device is approximately between 16 mm and 27 mm, the maximum width L3 inside the flow channel is approximately between 4.0-12.0 mm, the width L4 at the first and second openings of the flow channel (the minimum width inside the flow channel) is approximately between 0.3 mm and 0.8 mm, and the length L5 of the micropore array is approximately between 10.5-20.5 mm.
优选地,在一些实施例中,微孔阵列内的相邻微孔间距L6大于大约0.4mm。Preferably, in some embodiments, the distance L6 between adjacent microwells in the microwell array is greater than about 0.4 mm.
进一步地,在一些实施例中,微孔阵列内的相邻微孔间距L6大于大约0.5mm。Further, in some embodiments, the distance L6 between adjacent microwells in the microwell array is greater than about 0.5 mm.
出人意料的是,本发明的制备装置在选用了聚甲醛为原料制备出装置的流道和微孔等结构,并对相邻微孔之间的间距采用了新的尺寸设计后。既简化了装置的加工工艺,使得该装置能够通过多种类型的加工方式(如机械加工、激光加工等)制备得到,大大降低了装置的生产成本,并且同样能够满足一次性制备多个两亲性分子层的需求。并且,基于本发明所提供的制备装置,在成膜过程中无需对制备装置内的微孔进行预处理,成膜方法更加简单。Surprisingly, the preparation device of the present invention uses polyoxymethylene as a raw material to prepare the flow channel and micropores of the device, and adopts a new size design for the spacing between adjacent micropores. It simplifies the processing technology of the device, so that the device can be prepared by various types of processing methods (such as mechanical processing, laser processing, etc.), greatly reducing the production cost of the device, and can also meet the needs of preparing multiple amphiphilic molecular layers at one time. In addition, based on the preparation device provided by the present invention, there is no need to pre-treat the micropores in the preparation device during the film forming process, and the film forming method is simpler.
可以理解的是,本发明所提供的装置既能够应用于本发明所提出的新的成膜方法,同样也能够适用于现有的成膜方法,如涂布法等。It can be understood that the device provided by the present invention can be applied to the new film-forming method proposed by the present invention, and can also be applied to existing film-forming methods, such as coating methods.
在一些实施例中,制备装置的原料可以选取teflon(特氟龙),pmma(有机玻璃),delrin(聚甲醛,也即聚氧亚甲基)和parylene(聚对二甲苯)等材料。In some embodiments, the raw materials for preparing the device can be selected from materials such as teflon, pmma (plexiglass), delrin (polyoxymethylene, also known as polyoxymethylene) and parylene (polyparaxylene).
当然,在另一些实施例中,制备装置的原料还可以选用pmma(聚甲基丙烯酸甲酯)、环氧树脂、PC(聚碳酸酯),PVC(聚氯乙烯),COC(环烯烃类共聚物),聚酰亚胺等材料。Of course, in other embodiments, the raw materials for preparing the device can also be PMMA (polymethyl methacrylate), epoxy resin, PC (polycarbonate), PVC (polyvinyl chloride), COC (cycloolefin copolymer), polyimide and other materials.
进一步地,在一些实施例中,制备装置可以选用的加工方式包括:机械加工、激光加工、微注塑加工、3d打印的方式加工、铸造、电穿孔等等。Furthermore, in some embodiments, the processing methods that can be used to prepare the device include: mechanical processing, laser processing, micro injection molding, 3D printing, casting, electroporation, etc.
进一步地,在一些实施例中,制备装置中的微孔优选地采用激光加工。激光加工形成的微孔呈圆形且内壁光滑,容易形成两亲性分子层。Furthermore, in some embodiments, the micropores in the preparation device are preferably processed by laser. The micropores formed by laser processing are circular and have smooth inner walls, which are easy to form an amphiphilic molecule layer.
当然,在另一些实施例中,微孔也可以采用机械加工、电穿孔加工等。可以理解的是,微孔的加工满足微孔呈圆形,且侧壁光滑,容易形成两亲性分子层即可。Of course, in other embodiments, the micropores may also be processed by mechanical processing, electroporation processing, etc. It is understood that the processing of the micropores only requires that the micropores are round and have smooth side walls, and that the amphiphilic molecule layer is easily formed.
进一步地,在一些实施例中,制备装置本体的第一、二、三结构层可以分层加工,然后进行组装,也可以一体成型(如一体注塑成型),因此,无论是分层加工再组装,还是一体成型所得到的制备装置均属于本发明的保护范围内。Furthermore, in some embodiments, the first, second, and third structural layers of the preparation device body can be processed in layers and then assembled, or can be integrally formed (such as integral injection molding). Therefore, whether the preparation device is obtained by layered processing and then assembly, or integrally formed, it falls within the protection scope of the present invention.
例如,在一些实施例中,teflon材料可以通过微注塑的方式制造本装置;pmma可以通过机械加工或是微注塑的方式制造本装置,delrin可以通过机械加工或是微注塑的方式制造本装置,parylene可以通过物理气相沉积的方法,如把parylene沉积到别的加工好的材料表面制造本装置,沉积厚度优选为5微米For example, in some embodiments, teflon material can be manufactured by micro-injection molding; pmma can be manufactured by machining or micro-injection molding, delrin can be manufactured by machining or micro-injection molding, and parylene can be manufactured by physical vapor deposition, such as depositing parylene on the surface of other processed materials, with a deposition thickness of preferably 5 microns.
在一些实施例中,原材料选取具有一定疏水性和亲脂性的材料,由此可以在制备两亲性分子膜的过程中,减少预处理步骤,简化成膜方法,如优选地选用聚甲醛制成制备装置,聚甲醛的疏水性和亲脂性满足成膜要求,因此无需进行预处理。In some embodiments, the raw materials are selected from materials with certain hydrophobicity and lipophilicity, thereby reducing the pretreatment steps and simplifying the film-forming method in the process of preparing the amphiphilic molecular membrane. For example, polyformaldehyde is preferably used to make the preparation device. The hydrophobicity and lipophilicity of polyformaldehyde meet the film-forming requirements, so no pretreatment is required.
在一些实施例中,电极层中电极的材料可以是银,金,铂金和钛金电极,电极层可以通过磁控溅射或是PCB表面处理工艺制作。In some embodiments, the material of the electrodes in the electrode layer can be silver, gold, platinum and titanium electrodes, and the electrode layer can be manufactured by magnetron sputtering or PCB surface treatment process.
进一步地,在一些实施例中,当微孔的数量设置得较多时,在流道上还设有至少一个第三开口。Furthermore, in some embodiments, when the number of microholes is large, at least one third opening is also provided on the flow channel.
由于第三开口的最低处(即第三开口与流道相连的第二端)高于流道内的液面最高处,或者说,第三开口的第二端与流道内的液面高度齐平,因此,流道内的弯月面在移动过程中可以保持液面高度不变,因此能够保证形态的稳定,而不会受到第三开口的影响。Since the lowest point of the third opening (i.e., the second end of the third opening connected to the flow channel) is higher than the highest point of the liquid level in the flow channel, or in other words, the second end of the third opening is flush with the liquid level in the flow channel, the meniscus in the flow channel can maintain a constant liquid level during movement, thereby ensuring the stability of the shape without being affected by the third opening.
进一步地,在一些实施例中,为了便于加样,第一开口和第三开口可呈上大下小设置,例如,第一开口的第一端(设置在制备装置表面,用于加样的一端)大于第一开口的第二端(与流道连接的一端)。Furthermore, in some embodiments, in order to facilitate sample loading, the first opening and the third opening may be arranged to be larger at the top and smaller at the bottom. For example, the first end of the first opening (an end arranged on the surface of the preparation device and used for sample loading) is larger than the second end of the first opening (an end connected to the flow channel).
具体地,在一些实施例中,参见图1c,第三开口16设置在靠近第一开口12的一侧。本实施例相当于在流道上设置了双进样口(即设置了第一开口和第三开口两个进样口)。此时,第一开口(相当于第一进样口)用于加入膜溶液,以及用于通过往复式注射泵注入/回抽第二极性溶液,第二开口(相当于第二进样口)用来加入膜溶液。Specifically, in some embodiments, referring to FIG. 1c , the third opening 16 is disposed on a side close to the first opening 12. This embodiment is equivalent to providing a double injection port on the flow channel (i.e., providing two injection ports, the first opening and the third opening). At this time, the first opening (equivalent to the first injection port) is used to add the membrane solution, and to inject/withdraw the second polar solution through the reciprocating injection pump, and the second opening (equivalent to the second injection port) is used to add the membrane solution.
例如,在一些实施例中,当弯月面通过的微孔没有成膜时,说明此时弯月面中两亲性分子的浓度过低。此时,通过往复式注射泵在第一开口处回抽第二极性溶液,使得弯月面移动到第一开口和第三开口之间。在此过程中弯月面会再次流经已经成膜的微孔,由于两亲性分子层(即膜)本身是很稳定的排列结构,因此,当两亲性分子层已经在微孔上形成之后,此后即使弯月面多次重复地通过该微孔,也不会增加相应微孔上两亲性分子层的厚度。也即是说,弯月面往第一开口回移的过程并不会影响先前形成的膜。For example, in some embodiments, when the micropores through which the meniscus passes do not form a film, it indicates that the concentration of amphiphilic molecules in the meniscus is too low. At this time, the second polar solution is withdrawn at the first opening by a reciprocating syringe pump, so that the meniscus moves between the first opening and the third opening. In this process, the meniscus will flow through the micropores that have already formed a film again. Since the amphiphilic molecule layer (i.e., the film) itself is a very stable arrangement structure, after the amphiphilic molecule layer has been formed on the micropores, even if the meniscus repeatedly passes through the micropores many times, the thickness of the amphiphilic molecule layer on the corresponding micropores will not increase. In other words, the process of the meniscus moving back to the first opening does not affect the previously formed film.
进一步地,待弯月面移动到第一开口和第三开口之间时,再向第三开口(相当于第二进样口)中加入一定量的膜溶液,然后通过注射泵控制位于第一、三开口之间的弯月面继续沿第一开口到第三开口的方向移动,并与新加入的膜溶液组合成新的弯月面,新的弯月面继续在第二极性溶液的推动下经过未成膜的微孔,并在微孔上成膜。Furthermore, when the meniscus moves to between the first opening and the third opening, a certain amount of membrane solution is added to the third opening (equivalent to the second injection port), and then the meniscus located between the first and third openings is controlled by the injection pump to continue to move in the direction from the first opening to the third opening, and is combined with the newly added membrane solution to form a new meniscus. The new meniscus continues to pass through the unfilmed micropores under the push of the second polar solution and forms a film on the micropores.
因此,可以基于微孔的数量在流道上相应的设置一个或多个进样口,例如,当微孔数量相对较少时,两亲性分子的浓度的变化对成膜影响相对较小(或在实际应用过程中可以忽略浓度变化带来的影响)时,仅在流道上设置一个进样口即可,如仅设置用于进样的第一开口即可。Therefore, one or more injection ports can be correspondingly arranged on the flow channel based on the number of micropores. For example, when the number of micropores is relatively small and the change in the concentration of amphiphilic molecules has a relatively small effect on film formation (or the effect of the concentration change can be ignored in actual application), only one injection port is required on the flow channel, such as only the first opening for injection.
再例如,当微孔数量设置得相对较多时,随着弯月面经过一定量的微孔后,弯月面中的两亲性分子浓度逐渐降低,从而无法在后面的微孔处成膜。此时,可以在流道上设置多个进样口,例如,参见图1c,在流道上增设一个第三开口,用于添加液体样品。也即是说,可以通过在流道上增设进样口,进而增加微孔数量,使得制备装置能够一次性形成更多的两亲性分子层。For another example, when the number of micropores is set relatively large, as the meniscus passes through a certain number of micropores, the concentration of amphiphilic molecules in the meniscus gradually decreases, so that it is impossible to form a film at the subsequent micropores. In this case, multiple injection ports can be set on the flow channel. For example, referring to FIG. 1c, a third opening is added to the flow channel for adding liquid samples. In other words, by adding injection ports to the flow channel, the number of micropores can be increased, so that the preparation device can form more amphiphilic molecule layers at one time.
当然,在另一些实施例中,可以直接通过第三开口加入膜溶液,第一开口仅用于通过往复式注射泵注入/回抽第二极性溶液。Of course, in other embodiments, the membrane solution may be directly added through the third opening, and the first opening is only used to inject/withdraw the second polar solution through a reciprocating syringe pump.
在另一些实施例中,可以通过第三开口直接形成新的弯月面(使得在先形成的弯月面位于第一开口和第三开口之间,不再参与后续成膜),并使得新生成的弯月面移动并经过未成膜的微孔,并在微孔上成膜。In other embodiments, a new meniscus can be directly formed through the third opening (so that the previously formed meniscus is located between the first opening and the third opening and no longer participates in subsequent film formation), and the newly generated meniscus moves and passes through the unfilmed micropores and forms a film on the micropores.
优选地,为了对上述流程进行更准确地控制,可以通过自动化控制(如通过电脑软件控制的程序)实现。Preferably, in order to more accurately control the above process, it can be achieved through automated control (such as a program controlled by computer software).
实施例二Embodiment 2
基于实施例一,参见图5,本发明还提供了一种新的两亲性分子膜的制备方法(成膜方法),包括以下步骤:Based on Example 1, referring to FIG. 5 , the present invention further provides a novel method for preparing an amphiphilic molecular film (film forming method), comprising the following steps:
S1提供用于制备多个两亲性分子膜的制备装置,制备装置内设有多个微孔,以及能够使得溶液流向微孔的流道,制备装置内还包括电极层,使得流向微孔内的溶液可以与电极层相接触,其中,流道的横截面优选地呈方形或类方形设置;S1 provides a preparation device for preparing a plurality of amphiphilic molecular membranes, wherein the preparation device is provided with a plurality of micropores and a flow channel capable of allowing a solution to flow into the micropores, and the preparation device also includes an electrode layer, so that the solution flowing into the micropores can contact the electrode layer, wherein the cross section of the flow channel is preferably square or quasi-square;
S2向流道内加入第一极性溶液,使得第一极性溶液进入至少一个微孔,并与电极层相接触;S2: adding a first polar solution into the flow channel, so that the first polar solution enters at least one micropore and contacts the electrode layer;
S3依次向流道内加入膜溶液和第二极性溶液,使得膜溶液在流道内形成弯月面(参见图7a和图7b);S3: adding the membrane solution and the second polar solution into the flow channel in sequence, so that the membrane solution forms a meniscus in the flow channel (see FIG. 7a and FIG. 7b );
S4向流道内加入第二极性溶液,使得第二极性溶液推动膜溶液移动并流经第一极性溶液与电极层相接触的至少一个微孔,膜溶液中的两亲性分子在相应的微孔(即内有第一极性溶液,且第一极性溶液于电极层相接触的微孔)上形成两亲性分子层(具体地,两亲性分子基于自组装能力形成两亲性分子层)。其中,所述流道内表面的接触角为大约65°到120°。S4: adding a second polar solution into the flow channel, so that the second polar solution pushes the membrane solution to move and flow through at least one micropore where the first polar solution contacts the electrode layer, and the amphiphilic molecules in the membrane solution form an amphiphilic molecule layer on the corresponding micropore (i.e., the micropore where the first polar solution is contained and the first polar solution contacts the electrode layer) (specifically, the amphiphilic molecules form an amphiphilic molecule layer based on self-assembly ability). The contact angle of the inner surface of the flow channel is about 65° to 120°.
可以理解的是,在一些实施例中,上述步骤S3和S4可以连续进行(或者说,在实际操作过程中,步骤S3和步骤S4可以为一个步骤),当然,在另一些实施例,步骤S3和步骤S4也可以分步进行。It can be understood that, in some embodiments, the above steps S3 and S4 can be performed continuously (or, in actual operation, steps S3 and S4 can be one step). Of course, in other embodiments, steps S3 and S4 can also be performed in steps.
本实施例中,制备装置优先选用了具有一定疏水性的材料,且该制备装置内的流道内表面的材料的接触角为大约65°-120°,使得加入到流道内的膜溶液能够在流道内表面、极性溶液以及流道内的空气的共同作用下,形成弯月面。其中,流道的横截面优选地呈方形或类方形的设置,此时,流道对膜溶液(或者说膜溶液所形成的弯月面)的移动会产生一定的阻力,使得膜溶液在流道内的移动速度不会过快,且膜溶液上各个位置的移动速度相对均匀(或者说,各个位置的流动速度的差别对弯月面的稳定性影响不大),使得弯月面能够在移动过程中能够保持稳定的形态。In this embodiment, the preparation device preferably uses a material with a certain hydrophobicity, and the contact angle of the material on the inner surface of the flow channel in the preparation device is about 65°-120°, so that the membrane solution added to the flow channel can form a meniscus under the joint action of the inner surface of the flow channel, the polar solution and the air in the flow channel. Among them, the cross-section of the flow channel is preferably square or quasi-square. At this time, the flow channel will produce a certain resistance to the movement of the membrane solution (or the meniscus formed by the membrane solution), so that the movement speed of the membrane solution in the flow channel will not be too fast, and the movement speed of each position on the membrane solution is relatively uniform (or the difference in flow speed at each position has little effect on the stability of the meniscus), so that the meniscus can maintain a stable shape during the movement.
具体地,流道内表面以及微孔的表面(即微孔侧壁)均选用接触角在大约65°-120°之间的材料制成(优选地,由聚甲醛制成),使得膜溶液移动到对应的微孔处时,能够在微孔处(具体地,在微孔的第一端)上顺利形成两亲性分子膜,而无需提前对装置(如设置在流道处的微孔)进行预处理。Specifically, the inner surface of the flow channel and the surface of the micropore (i.e., the side wall of the micropore) are both made of a material with a contact angle between approximately 65° and 120° (preferably, made of polyformaldehyde), so that when the membrane solution moves to the corresponding micropores, an amphiphilic molecular membrane can be smoothly formed at the micropores (specifically, at the first end of the micropores) without the need to pre-treat the device (such as the micropores arranged at the flow channel) in advance.
其中,在膜溶液形成弯月面与弯月面移动过程中,膜溶液的加入量(体积)、膜溶液所形成弯月面的移动速度对弯月面的形成与移动过程也非常重要,并且对于本领域的技术人员来说,通过预实验选取适合的膜溶液加入量、移动速度是可以实现的。Among them, in the process of formation of meniscus and movement of meniscus by membrane solution, the amount (volume) of membrane solution added and the movement speed of the meniscus formed by the membrane solution are also very important to the formation and movement process of the meniscus, and for technicians in this field, it is achievable to select appropriate amount of membrane solution added and movement speed through preliminary experiments.
例如,在膜溶液的加入量的选择或预测步骤中,主要考虑的参数有:雷诺数(Reynolds number,即Re),雷诺数是一种可用来表征流体流动情况的无量纲数。雷诺数的计算方法为:Re=ρvd/μ,其中v、ρ、μ分别为流体的流速(相当于膜溶液的移动速度)、密度与黏性系数,d为特征长度(相当于流道的长度)。其中,膜溶液的密度和粘度系数均可以通过实验测量得到,保持弯月面的稳定需要使得流体的雷诺系数偏小(雷诺数越小,流体流动越稳定),即为层流状态。For example, in the step of selecting or predicting the amount of membrane solution added, the main parameters to be considered are: Reynolds number (Re), which is a dimensionless number that can be used to characterize the flow of fluid. The calculation method of Reynolds number is: Re = ρvd/μ, where v, ρ, and μ are the flow velocity (equivalent to the movement velocity of the membrane solution), density, and viscosity coefficient of the fluid, respectively, and d is the characteristic length (equivalent to the length of the flow channel). Among them, the density and viscosity coefficient of the membrane solution can be obtained through experimental measurement. To maintain the stability of the meniscus, the Reynolds coefficient of the fluid needs to be small (the smaller the Reynolds number, the more stable the fluid flow), that is, the laminar flow state.
因此,本发明优选地使得流体的Re<2300,由此,通过雷诺数可以对流道的长度与膜溶液的移动速度的关系作出了初步限制(因此,当膜溶液选定,且装置的流道长度(流道长度与微孔阵列的设置有关)已确定时,膜溶液的移动速度可以基于雷诺数作出初步限制,也即膜溶液的移动速度受到了膜溶液与流道长度的约束)。也即是说,对于本领域技术人员而言,当膜溶液选定后,在此基础上选用制备装置进行预实验,能够筛选出选取较为合适的膜溶液的移动速度。基于预实验筛选出的移动速度对极性溶液(如第二极性溶液)的注入速度进行对应的设计,可以得到第二极性溶液的预设的注入速度(如步骤S3、S4中第二极性溶液的注入速度)。当然,第二极性溶液的注入速度也可以提供工作人员的操作经验作出初步预估,然后进行预实验,从而获取到适宜的注入速度。Therefore, the present invention preferably makes the Re of the fluid <2300, thereby, the Reynolds number can be used to make a preliminary restriction on the relationship between the length of the flow channel and the movement speed of the membrane solution (therefore, when the membrane solution is selected and the flow channel length of the device (the flow channel length is related to the setting of the micropore array) is determined, the movement speed of the membrane solution can be preliminarily restricted based on the Reynolds number, that is, the movement speed of the membrane solution is constrained by the membrane solution and the flow channel length). In other words, for those skilled in the art, after the membrane solution is selected, a preparation device is selected on this basis for preliminary experiments, and a more suitable movement speed of the membrane solution can be screened out. Based on the movement speed screened out in the preliminary experiment, the injection speed of the polar solution (such as the second polar solution) is designed accordingly, and the preset injection speed of the second polar solution (such as the injection speed of the second polar solution in steps S3 and S4) can be obtained. Of course, the injection speed of the second polar solution can also provide the operating experience of the staff to make a preliminary estimate, and then conduct a preliminary experiment to obtain a suitable injection speed.
进一步地,在一些实施例中,流道内表面所选材料的接触角为大约75°-大约95°。具体地,在一些实施例中,多个微孔设置在流道内表面,也即流道内表面以及微孔表面所选材料的接触角为大约75°-大约95°。Further, in some embodiments, the contact angle of the material selected for the inner surface of the flow channel is about 75° to about 95°. Specifically, in some embodiments, a plurality of micropores are disposed on the inner surface of the flow channel, that is, the contact angle of the material selected for the inner surface of the flow channel and the micropore surface is about 75° to about 95°.
优选地,流道内表面与微孔表面均采用聚甲醛加工制成。Preferably, the inner surface of the flow channel and the microporous surface are both made of polyoxymethylene.
进一步地,在一些实施例中,在形成弯月面的过程中(即步骤S3中),第二极性溶液的注入速度在大约10μL/min到大约50μL/min,在弯月面形成后通过微孔阵列的过程中(即步骤S4中),第二极性溶液的注入速度大约是200μL/min到大约500μL/min。Further, in some embodiments, during the process of forming the meniscus (i.e., step S3), the injection rate of the second polar solution is about 10 μL/min to about 50 μL/min, and during the process of passing through the micropore array after the meniscus is formed (i.e., step S4), the injection rate of the second polar solution is about 200 μL/min to about 500 μL/min.
为了更清楚地说明本发明所采用的技术方案,下面对接触角、弯月面的形成进行简单说明:In order to more clearly illustrate the technical solution adopted by the present invention, the formation of the contact angle and the meniscus is briefly described below:
参见图9a,接触角(contact angle)是指在固体S、液体L、气体G三相交界处,自固-液界面经过液体内部到气-液界面之间的夹角。若θ<90°,即液体较易润湿固体,其角越小,表示润湿性越好;若θ>90°,即液体不容易润湿固体,容易在表面上移动。具体地,当θ=0,完全润湿;当θ<90°,部分润湿或润湿;当θ=90°,是润湿与否的分界线;当θ>90°,不润湿;当θ=180°,完全不润湿。Referring to Figure 9a, the contact angle refers to the angle between the solid-liquid interface, the liquid L, and the gas G at the junction of the three phases, from the solid-liquid interface through the liquid to the gas-liquid interface. If θ<90°, the liquid is easier to wet the solid, and the smaller the angle, the better the wettability; if θ>90°, the liquid is not easy to wet the solid and is easy to move on the surface. Specifically, when θ=0, it is completely wetted; when θ<90°, it is partially wetted or wetted; when θ=90°, it is the dividing line between wettability and non-wetting; when θ>90°, it is non-wetting; when θ=180°, it is completely non-wetting.
参见图9b,沿图中的毛细管壁升高的液体压强为其中,Δp为沿毛细管壁上升的液体的压强,σ为表面张力,R为液体表面的曲率半径,ρ为液体密度,g为重力加速度,h为液面升高的高度。基于接触角的定义可知:例如,当接触角θ小于90°时,溶液可以在毛细管内形成弯月面,且此时所形成的弯月面为凹状。同时可知所形成弯月面的曲率半径和毛细管的半径r有关,当接触角θ大于90°时,溶液可以在毛细管内形成凸状的弯月面。Referring to FIG9b, the liquid pressure rising along the capillary wall in the figure is Among them, Δp is the pressure of the liquid rising along the capillary wall, σ is the surface tension, R is the radius of curvature of the liquid surface, ρ is the liquid density, g is the acceleration of gravity, and h is the height of the liquid surface. Based on the definition of contact angle, we can know that: For example, when the contact angle θ is less than 90°, the solution can form a meniscus in the capillary, and the meniscus formed at this time is concave. At the same time, it can be known that the radius of curvature of the formed meniscus is related to the radius r of the capillary. When the contact angle θ is greater than 90°, the solution can form a convex meniscus in the capillary.
具体地,加入流道内部的极性溶液(如第二极性溶液)的表面张力使得膜溶液在极性溶液的液体表面(即与膜溶液相接触的一端)扩散开来。由于流道内表面选用的是具有一定疏水性的材料,因此,流道内表面对膜溶液有一定的吸附作用。此时,参见图7b,膜溶液一边是极性溶液(第二极性溶液2),另一边是空气8。其中,液体表面有收缩力,膜溶液与空气接触的界面层分子受到一指向液体内部的拉力,从而使得膜溶液在流道内部逐渐形成弯月面4,如参见图7b)。Specifically, the surface tension of the polar solution (such as the second polar solution) added to the inside of the flow channel causes the membrane solution to spread on the liquid surface of the polar solution (i.e., the end in contact with the membrane solution). Since the inner surface of the flow channel is made of a material with a certain hydrophobicity, the inner surface of the flow channel has a certain adsorption effect on the membrane solution. At this time, referring to FIG7b, one side of the membrane solution is the polar solution (the second polar solution 2), and the other side is air 8. Among them, the liquid surface has a contraction force, and the molecules in the interface layer where the membrane solution contacts the air are subjected to a pulling force directed toward the inside of the liquid, so that the membrane solution gradually forms a meniscus 4 inside the flow channel, as shown in FIG7b).
参见图7a,膜溶液里溶解有两亲性分子5,其中两亲性分子5有亲水端52和疏水端51(参见图6)。由于两亲性分子具有自组装能力,当膜溶液流过微孔时,里面的两亲性分子的亲水端52会指向并接触第一极性溶液,而疏水端51会和另外一层两亲性分子的疏水端51相组合,从而形成两亲性分子层,如图7a和图8所示。本实施例中,通过控制膜溶液的移动速度,可以避免两亲性分子在微孔处堆积越来越厚(如图10中的(a)所示)造成无法嵌孔。Referring to FIG. 7a, amphiphilic molecules 5 are dissolved in the membrane solution, wherein the amphiphilic molecules 5 have a hydrophilic end 52 and a hydrophobic end 51 (see FIG. 6). Since the amphiphilic molecules have the ability to self-assemble, when the membrane solution flows through the micropores, the hydrophilic end 52 of the amphiphilic molecules inside will point to and contact the first polar solution, while the hydrophobic end 51 will combine with the hydrophobic end 51 of another layer of amphiphilic molecules to form an amphiphilic molecule layer, as shown in FIG. 7a and FIG. 8. In this embodiment, by controlling the movement speed of the membrane solution, it is possible to avoid the amphiphilic molecules from accumulating thicker and thicker at the micropores (as shown in FIG. 10 (a)), which makes it impossible to embed the pores.
本实施例中,通过第二极性溶液推动膜溶液发生移动,从而使得膜溶液经过至少一个微孔,并在至少一个微孔处形成两亲性分子膜。且第二极性溶液的流速(或者说第二极性溶液的加样速度/注入速度)相对可控,由此可以通过控制后续加入第二极性溶液的加样速度控制膜溶液在流道中的移动速度(也即流动速度),从而控制两亲性分子膜的形成过程,避免膜溶液流动过快而没有成功形成两亲性分子膜,或者膜溶液流动过慢而形成过厚的两亲性分子膜。In this embodiment, the membrane solution is pushed to move by the second polar solution, so that the membrane solution passes through at least one micropore and forms an amphiphilic molecular membrane at at least one micropore. The flow rate of the second polar solution (or the sampling speed/injection speed of the second polar solution) is relatively controllable, so the movement speed (i.e., flow speed) of the membrane solution in the flow channel can be controlled by controlling the sampling speed of the subsequent addition of the second polar solution, thereby controlling the formation process of the amphiphilic molecular membrane, avoiding the membrane solution flowing too fast and failing to successfully form an amphiphilic molecular membrane, or the membrane solution flowing too slowly and forming an overly thick amphiphilic molecular membrane.
通过极性溶液推动弯月面(膜溶液)在微孔处成膜的成膜方式,可以对膜溶液的移动速度进行较为精准的控制(例如,通过移液枪或注射泵等对极性溶液的注入速度进行控制,从而对膜溶液的移动速度进行控制),从而使得膜溶液在不同的微孔处停留时间相同或相近,避免膜溶液在部分微孔区域停留过久而形成厚的膜,或者在部分微孔区域移动过快而没有成功形成膜。因此,本发明能够通过对膜溶液的移动速度进行较为精准的控制,从而直接制成膜厚符合使用要求的两亲性分子层,而无需在成膜后对膜进行薄化处理(如通过薄化处理使得膜由厚变薄,如图10中的(a)-(d)所示)。换句话说,本发明的成膜方法可以一次成膜,成膜效果较好,如通过控制极性溶液的注入速度进而控制膜溶液的移动速度,可以直接形成厚度适宜的膜,如直接制备出图10中的(d)所示的膜。By using a polar solution to push the meniscus (membrane solution) to form a film at the micropore, the moving speed of the membrane solution can be controlled more accurately (for example, the injection speed of the polar solution is controlled by a pipette gun or a syringe pump, so as to control the moving speed of the membrane solution), so that the membrane solution stays at different micropores for the same or similar time, avoiding the membrane solution staying in some micropore areas for too long to form a thick film, or moving too fast in some micropore areas without successfully forming a film. Therefore, the present invention can directly form an amphiphilic molecular layer with a film thickness that meets the use requirements by more accurately controlling the moving speed of the membrane solution, without the need to thin the film after film formation (such as thinning the film from thick to thin, as shown in (a)-(d) in Figure 10). In other words, the film forming method of the present invention can form a film once, and the film forming effect is better. For example, by controlling the injection speed of the polar solution and then controlling the moving speed of the membrane solution, a film of suitable thickness can be directly formed, such as directly preparing the film shown in (d) in Figure 10.
例如,在一些实施例中,通过注射泵控制第二极性溶液的注入速度,以控制膜溶液的移动速度。本实施例中,所提供的方法更可控(例如,相较于现有技术的气泡挤压成膜)。当然,还可以采用其他注入方式以控制溶液的注入速度,且任何能够控制溶液注入速度的方式均属于本发明的保护范围内。For example, in some embodiments, the injection speed of the second polar solution is controlled by a syringe pump to control the movement speed of the membrane solution. In this embodiment, the method provided is more controllable (for example, compared to the bubble extrusion film forming of the prior art). Of course, other injection methods can also be used to control the injection speed of the solution, and any method that can control the injection speed of the solution belongs to the protection scope of the present invention.
进一步地,在一些实施例中,提供往复式注射泵加入(注入)第二极性溶液。例如,选用的注射泵型号为harvard apparatus 4400。Furthermore, in some embodiments, a reciprocating syringe pump is provided to add (inject) the second polar solution. For example, the syringe pump model selected is Harvard Apparatus 4400.
优选地,在一些实施例中,在S1之前,包括步骤:对至少一个微孔进行润湿处理。Preferably, in some embodiments, before S1, a step is included: performing a wetting treatment on at least one micropore.
本实施例中,通过润湿处理使得液体(如第一极性溶液)在固体表面(如微孔表面)能够铺展,扩大极性溶液与流道内壁接触面积,减小接触角,从而使得第一极性溶液能够顺利进入至少一个微孔中,并充满微孔。In this embodiment, the wetting treatment is used to allow the liquid (such as the first polar solution) to spread on the solid surface (such as the micropore surface), thereby expanding the contact area between the polar solution and the inner wall of the flow channel and reducing the contact angle, so that the first polar solution can smoothly enter at least one micropore and fill the micropore.
例如,在一些实施例中,润湿处理为电润湿处理。For example, in some embodiments, the wetting process is an electrowetting process.
例如,在一些实施例中,润湿处理为液体润湿处理。For example, in some embodiments, the wetting process is a liquid wetting process.
具体地,在一些实施例中,首先向所述流道内通入低表面能的液体(如乙醇等),低表面能的液体可以流入很小的孔隙,如微孔内,再加入极性溶液就可以使得极性溶液充满微孔,如果不预先加入低表面能的液体,则极性溶液可能无法直接流入微孔。然后向所述流道内通入第一极性溶液,使得第一极性溶液充满至少一个微孔,并稀释、排出低表面能液体。先前通入的低表面能液体使得第一极性溶液更容易充满微孔,其中,低表面能的液体包括:乙醇等。Specifically, in some embodiments, a low surface energy liquid (such as ethanol, etc.) is first introduced into the flow channel. The low surface energy liquid can flow into very small pores, such as micropores. Then, a polar solution is added to fill the micropores. If a low surface energy liquid is not added in advance, the polar solution may not be able to flow directly into the micropores. Then, a first polar solution is introduced into the flow channel so that the first polar solution fills at least one micropore, and the low surface energy liquid is diluted and discharged. The low surface energy liquid previously introduced makes it easier for the first polar solution to fill the micropores, wherein the low surface energy liquid includes: ethanol, etc.
在另一些实施例中,在步骤S2中还包括步骤:在向所述流道内加入第一极性溶液之后,对所述制备装置进行超声处理,使得第一极性溶液在声波作用下进入到微孔。In some other embodiments, step S2 further includes the step of: after adding the first polar solution into the flow channel, ultrasonically treating the preparation device so that the first polar solution enters the micropores under the action of the sound waves.
进一步地,在一些实施例中,上述膜溶液为含有两亲性分子的非极性溶液。Furthermore, in some embodiments, the membrane solution is a non-polar solution containing amphiphilic molecules.
进一步地,在一些实施例中,两亲性分子可以是磷脂,可以是高分子,例如两亲性分子还可以是通过物理化学方法合成的高分子材料,ABA三嵌段共聚物(PMOXA-PDMS-PMOXA二甲基恶唑啉-聚二甲基硅氧烷-二甲基恶唑啉),或是磷脂和高分子的混合物。Furthermore, in some embodiments, the amphiphilic molecule can be a phospholipid or a polymer. For example, the amphiphilic molecule can also be a polymer material synthesized by physical and chemical methods, ABA triblock copolymer (PMOXA-PDMS-PMOXA dimethyloxazoline-polydimethylsiloxane-dimethyloxazoline), or a mixture of phospholipids and polymers.
进一步地,在一些实施例中,非极性溶液可以是烷烃类有机溶剂,包含癸烷,十六烷,戊烷,或是他们的混合液,该非极性溶液用来溶解磷脂或是高分子三嵌段共聚物制成膜溶液。Furthermore, in some embodiments, the non-polar solution can be an alkane organic solvent, including decane, hexadecane, pentane, or a mixture thereof, and the non-polar solution is used to dissolve phospholipids or high molecular triblock copolymers to prepare a membrane solution.
进一步地,在一些实施例中,第二极性溶液和第一极性溶液可以相同,也可以为不同的极性溶液。所选用的极性溶液满足导电作用,并能够使得纳米孔蛋白能够插入两亲性分子层上即可。Furthermore, in some embodiments, the second polar solution and the first polar solution may be the same or different polar solutions. The selected polar solution only needs to satisfy the conductive function and enable the nanopore protein to be inserted into the amphiphilic molecule layer.
进一步地,在一些实施例中,纳米孔蛋白可以预先添加在极性溶液(如第一极性溶液或第二极性溶液中)。Furthermore, in some embodiments, the nanopore protein may be pre-added in a polar solution (such as a first polar solution or a second polar solution).
当然,在另一些实施例中,也可以在两亲性分子层形成后,向流道内加入纳米孔蛋白(如包括纳米孔蛋白的溶液)。Of course, in other embodiments, nanoporous protein (such as a solution including nanoporous protein) may be added into the flow channel after the amphiphilic molecule layer is formed.
进一步地,在一些实施例中,极性溶液为基因测序过程中的电解液,包含电解质和/或聚电解质用来有效提升离子交换寿命;也可以包含氧化还原对,和/或可以被部分氧化或还原以提供氧化还原对的氧化还原对的组合,例如铁/压铁氰化物;也可以是交联的琼脂糖凝胶,和/或交联的海藻酸钠凝胶;也可以包含有缓冲剂用来调节水溶液介质的pH,适当的缓冲剂(缓冲液)包括但不限于磷酸缓冲液PBS、4-双-2-乙烷磺酸缓冲剂PIPES、N-2-羟乙基哌嗪-N’-乙烷磺酸缓冲剂(HEPES)等。Furthermore, in some embodiments, the polar solution is an electrolyte in the gene sequencing process, comprising electrolytes and/or polyelectrolytes to effectively improve the ion exchange life; it may also comprise redox pairs, and/or combinations of redox pairs that can be partially oxidized or reduced to provide redox pairs, such as iron/ferrocyanide; it may also be a cross-linked agarose gel, and/or a cross-linked sodium alginate gel; it may also comprise a buffer to adjust the pH of the aqueous solution medium, and suitable buffers (buffers) include but are not limited to phosphate buffer PBS, 4-bis-2-ethanesulfonic acid buffer PIPES, N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid buffer (HEPES), etc.
进一步地,在一些实施例中,该方法还包括步骤:Furthermore, in some embodiments, the method further comprises the steps of:
通过电极层和公用电极向极性溶液通电,使得纳米孔蛋白在电压作用下嵌入(插入)两亲性分子层中。Electricity is supplied to the polar solution through the electrode layer and the common electrode, so that the nanopore protein is embedded (inserted) into the amphiphilic molecule layer under the action of voltage.
例如,在一些实施例中,将公用电极插入到装置的第二开口(或第一开口或电极插入口)内,然后通过公用电极和预设的电极层向极性溶液通电。例如,公用电极为插针,PET柔性电极,或是和微流控芯片夹具一体设计的电极连接到电路部分。For example, in some embodiments, the common electrode is inserted into the second opening (or the first opening or the electrode insertion port) of the device, and then the polar solution is electrified through the common electrode and the preset electrode layer. For example, the common electrode is a pin, a PET flexible electrode, or an electrode designed integrally with the microfluidic chip fixture connected to the circuit part.
具体地,在一些实施例中,当流道的内径设置得较大(或者说,流道较宽时),为了使得弯月面能够成功形成,本方法所涉及的制备装置的流道包括:第一开口、第二开口,且第一开口和第二开口通过第一流道15相连通。参见图11a,第一开口12的内径相对较小,第一流道15的内径相对较宽,因此,流道的第一端(即与第一开口相连的一端)存在一段尺寸变化的区域,即流道从第一开口12到第一流道15的方向上内径逐渐增加(或者说,流道的第一端的内径沿远离第一开口的方向逐渐增大)。Specifically, in some embodiments, when the inner diameter of the flow channel is set larger (or, the flow channel is wider), in order to successfully form the meniscus, the flow channel of the preparation device involved in the method includes: a first opening, a second opening, and the first opening and the second opening are connected through the first flow channel 15. Referring to FIG. 11a, the inner diameter of the first opening 12 is relatively small, and the inner diameter of the first flow channel 15 is relatively wide. Therefore, there is a region of size change at the first end of the flow channel (i.e., the end connected to the first opening), that is, the inner diameter of the flow channel gradually increases in the direction from the first opening 12 to the first flow channel 15 (or, the inner diameter of the first end of the flow channel gradually increases in the direction away from the first opening).
当膜溶液通过第一开口加入流道内部时,膜溶液先进入内径较小的流道的第一端,此时流道内部空间较窄,膜溶液所形成的弯月面较厚,形态也相对稳定。因此,膜溶液在前期的移动速度可以设置得较快(具体地,由于从流道的入口处到流道内部之间存在一段内径由小变大的区域。此时极性溶液的注入速度相对较慢,但是由于流道的横截面比较小,因此即使极性溶液的注入速度相对较慢,也能使得弯月面的具有相对较快的移动速度),当膜溶液逐渐移动到流道内径最大的区域(如设置在流道的两端之间的中间区域,即内径相等区)时,膜溶液所形成的弯月面逐渐被拉伸变薄,弯月面的稳定性相对降低,此时需要适当减小膜溶液的移动速度(此时,由于流道对应于微孔处区域的横截面较大,当极性溶液保持原有注入速度时,弯月面的移动速度也会减小;当然,可以通过调小极性溶液的注入速度,以进一步地减小膜溶液的移动速度)。本实施例中,流道在尺寸上的渐变设计使得弯月面的形成与变化过程中形态相对稳定,不易发生破坏,其中,弯月面在流道内移动过程中的不同状态如图11b中的弯月面的第一、二、三状态4a、4b、4c所示。When the membrane solution is added into the flow channel through the first opening, the membrane solution first enters the first end of the flow channel with a smaller inner diameter. At this time, the internal space of the flow channel is narrow, the meniscus formed by the membrane solution is thicker, and the shape is relatively stable. Therefore, the movement speed of the membrane solution in the early stage can be set faster (specifically, since there is a region where the inner diameter changes from small to large between the entrance of the flow channel and the inside of the flow channel. At this time, the injection speed of the polar solution is relatively slow, but since the cross-section of the flow channel is relatively small, even if the injection speed of the polar solution is relatively slow, the meniscus can have a relatively fast movement speed). When the membrane solution gradually moves to the area with the largest inner diameter of the flow channel (such as the middle area between the two ends of the flow channel, that is, the area with equal inner diameters), the meniscus formed by the membrane solution is gradually stretched and thinned, and the stability of the meniscus is relatively reduced. At this time, it is necessary to appropriately reduce the movement speed of the membrane solution (at this time, since the cross-section of the flow channel corresponding to the micropore area is larger, when the polar solution maintains the original injection speed, the movement speed of the meniscus will also decrease; of course, the injection speed of the polar solution can be reduced to further reduce the movement speed of the membrane solution). In this embodiment, the gradual change in size of the flow channel makes the shape of the meniscus relatively stable during its formation and change, and not easily damaged. The different states of the meniscus during its movement in the flow channel are shown in the first, second, and third states 4a, 4b, and 4c of the meniscus in Figure 11b.
例如,在一些实施例中,参见图11a,流道的内径发生变化区域(即内径不等区,也即流道的第一端)包括:相连的第一变化区和第二变化区,其中,第一变化区(靠近第一开口处)的侧壁的曲线设置与半径为R1的圆的部分圆弧相似(或者说,第一变化区的侧壁的竖直投影呈曲线设置),第二变化区的侧壁的曲线设置与半径为R2的圆的部分圆弧相似(或者说,第二变化区的侧壁的竖直投影呈曲线设置)。其中,R1和R2相等(当然,在另一些实施例中,R1和R2也可以不等,只要流道的内径能够实现弯月面的形成和移动即可)。For example, in some embodiments, referring to FIG. 11a, the region where the inner diameter of the flow channel changes (i.e., the region with unequal inner diameters, i.e., the first end of the flow channel) includes: a first change region and a second change region connected, wherein the curve setting of the side wall of the first change region (near the first opening) is similar to a partial arc of a circle with a radius of R1 (or, the vertical projection of the side wall of the first change region is set in a curve), and the curve setting of the side wall of the second change region is similar to a partial arc of a circle with a radius of R2 (or, the vertical projection of the side wall of the second change region is set in a curve). Among them, R1 and R2 are equal (of course, in other embodiments, R1 and R2 may also be unequal, as long as the inner diameter of the flow channel can achieve the formation and movement of the meniscus).
在一些实施例中,流道与第二开口相连的流道第二端的设置方式与流道的第一端相同或相似。In some embodiments, the second end of the flow channel connected to the second opening is configured in the same or similar manner as the first end of the flow channel.
例如,在一具体实施例中(采用设置8*32个微孔的制备装置),制备方法具体包括步骤:For example, in a specific embodiment (using a preparation device with 8*32 micropores), the preparation method specifically includes the steps of:
首先向流道内加入纯乙醇,使得乙醇进入至少一个微孔内,然后向流道内加入极性溶液稀释并排净乙醇,从而使得该极性溶液充满至少一个微孔内,并接触电极层(相当于第一电极);First, pure ethanol is added into the flow channel so that the ethanol enters at least one micropore, and then a polar solution is added into the flow channel to dilute and drain the ethanol, so that the polar solution fills at least one micropore and contacts the electrode layer (equivalent to the first electrode);
向第一开口内加入大约20微升-大约50微升的膜溶液;Adding about 20 μl to about 50 μl of membrane solution into the first opening;
向第一开口内加入大约20微升-大约50微升的极性溶液,使得所述膜溶液在流道内形成弯月面;Adding about 20 microliters to about 50 microliters of a polar solution into the first opening so that the membrane solution forms a meniscus in the flow channel;
通过注射泵按照预设的注入速度(流速)向第一开口加入大约300微升的极性溶液;具体地,前100微升极性溶液采用10微升/每分钟的流速(此过程中,弯月面形成且逐渐变薄),后200微升极性溶液采用5微升/每分钟的流速,从而使得弯月面能够保持形状的稳定且匀速流过微孔阵列,微孔阵列上50%到80%的微孔上可以直接形成两亲性分子层。About 300 microliters of polar solution are added to the first opening through a syringe pump at a preset injection speed (flow rate); specifically, the first 100 microliters of polar solution adopts a flow rate of 10 microliters per minute (during this process, a meniscus is formed and gradually becomes thinner), and the last 200 microliters of polar solution adopts a flow rate of 5 microliters per minute, so that the meniscus can maintain a stable shape and flow through the micropore array at a uniform speed, and an amphiphilic molecule layer can be directly formed on 50% to 80% of the micropores on the micropore array.
或者,在另一具体实施例中(采用设有16个微孔的制备装置),制备方法包括步骤:Alternatively, in another specific embodiment (using a preparation device having 16 microwells), the preparation method comprises the steps of:
首先向流道内加入纯乙醇,然后加入极性溶液稀释排净乙醇,从而使得微孔里充满极性溶液,且极性溶液与电极层相接触;First, pure ethanol is added into the flow channel, and then a polar solution is added to dilute and drain the ethanol, so that the micropores are filled with the polar solution and the polar solution is in contact with the electrode layer;
向第一开口加入大约8到大约12微升的膜溶液;adding about 8 to about 12 microliters of membrane solution to the first opening;
然后向第一开口加入大约8到大约12微升的极性溶液,使得膜溶液形成弯月面;Then, adding about 8 to about 12 microliters of a polar solution to the first opening so that the membrane solution forms a meniscus;
接着基于预设的注入速度(流速)向第一开口加入大约60微升极性溶液,具体地,前15微升的极性溶液采用4微升/每分钟的流速,后45微升的极性溶液采用2微升/每分钟的流速,从而保持弯月面形状的稳定,且使得膜溶液能够匀速流过微孔阵列。其中,微孔阵列上50%到80%的微孔上可以直接形成两亲性分子层。Then, based on the preset injection speed (flow rate), about 60 microliters of polar solution are added to the first opening, specifically, the first 15 microliters of polar solution adopts a flow rate of 4 microliters/minute, and the last 45 microliters of polar solution adopts a flow rate of 2 microliters/minute, so as to maintain the stability of the meniscus shape and enable the membrane solution to flow through the micropore array at a uniform speed. Among them, 50% to 80% of the micropores on the micropore array can directly form an amphiphilic molecule layer.
当然,本发明所提供的成膜方法和制备装置并不完全排斥预处理操作,如基于不同的检测需求,本领域技术人员也可以相应地需要增加预处理步骤。Of course, the film forming method and preparation device provided by the present invention do not completely exclude pretreatment operations. For example, based on different detection requirements, those skilled in the art may also need to add pretreatment steps accordingly.
进一步地,在一些实施例中,还包括步骤:对所述两亲性分子层进行检测。Furthermore, in some embodiments, the method further comprises the step of: detecting the amphiphilic molecule layer.
例如,通过向两亲性分子层输入三角波信号,随后会得到相应的方波信号,通过方波信号的上下峰值可以判断出两亲性分子层是否形成,以及两亲性分子层是否满足要求。具体地,当检测出两亲性分子层过厚时,可以适当减少膜溶液的浓度。For example, by inputting a triangle wave signal into the amphiphilic molecule layer, a corresponding square wave signal is obtained, and the upper and lower peak values of the square wave signal can be used to determine whether the amphiphilic molecule layer is formed and whether the amphiphilic molecule layer meets the requirements. Specifically, when it is detected that the amphiphilic molecule layer is too thick, the concentration of the membrane solution can be appropriately reduced.
具体地,选用商用AXON 1550B仪器检测电信号或是输出三角波,以测量膜两端的电容来判断是否形成两亲性分子层。Specifically, a commercial AXON 1550B instrument is used to detect electrical signals or output triangular waves to measure the capacitance at both ends of the membrane to determine whether an amphiphilic molecular layer is formed.
需要说明的是,在本文中,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者装置不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者装置所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括该要素的过程、方法、物品或者装置中还存在另外的相同要素。It should be noted that, in this article, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the existence of other identical elements in the process, method, article or device including the element.
以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围,其均应涵盖在本发明的权利要求和说明书的范围当中。The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the above embodiments, those skilled in the art should understand that the technical solutions described in the above embodiments may still be modified, or some or all of the technical features may be replaced by equivalents. Such modifications or replacements do not deviate the essence of the corresponding technical solutions from the scope of the technical solutions of the embodiments of the present invention, and should all be included in the scope of the claims and specification of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410598638.3A CN118835255A (en) | 2022-04-14 | 2022-04-14 | Preparation method and device for multiple amphiphilic molecule layers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210391473.3A CN114908358B8 (en) | 2022-04-14 | 2022-04-14 | Preparation method and device of amphiphilic molecular layer |
CN202410598638.3A CN118835255A (en) | 2022-04-14 | 2022-04-14 | Preparation method and device for multiple amphiphilic molecule layers |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210391473.3A Division CN114908358B8 (en) | 2022-04-14 | 2022-04-14 | Preparation method and device of amphiphilic molecular layer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118835255A true CN118835255A (en) | 2024-10-25 |
Family
ID=82763986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410598638.3A Pending CN118835255A (en) | 2022-04-14 | 2022-04-14 | Preparation method and device for multiple amphiphilic molecule layers |
CN202210391473.3A Active CN114908358B8 (en) | 2022-04-14 | 2022-04-14 | Preparation method and device of amphiphilic molecular layer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210391473.3A Active CN114908358B8 (en) | 2022-04-14 | 2022-04-14 | Preparation method and device of amphiphilic molecular layer |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN118835255A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117384486B (en) * | 2023-02-10 | 2025-06-27 | 北京普译生物科技有限公司 | Mixed bionic membrane and preparation method and application thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5114702B2 (en) * | 2005-07-29 | 2013-01-09 | 国立大学法人 東京大学 | Method and apparatus for forming bilayer film by contact with amphiphilic monolayer |
GB0724736D0 (en) * | 2007-12-19 | 2008-01-30 | Oxford Nanolabs Ltd | Formation of layers of amphiphilic molecules |
CN102072971A (en) * | 2009-11-20 | 2011-05-25 | 复旦大学 | Method for preparing lipid bilayer membrane in liquid phase in situ |
DE102010022929B4 (en) * | 2010-06-07 | 2013-07-18 | Albert-Ludwigs-Universität Freiburg | Method for producing a bilipid layer and microstructure and measuring arrangement |
GB201202519D0 (en) * | 2012-02-13 | 2012-03-28 | Oxford Nanopore Tech Ltd | Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules |
BR112014020211A2 (en) * | 2012-02-16 | 2017-07-04 | Oxford Nanopore Tech Ltd | methods for analyzing a time-ordered series of polymer measurements, for estimating the presence, absence, or amount of a target polymer, and for determining a change in a polymer, computer program, and diagnostic and diagnostic devices. |
GB201313121D0 (en) * | 2013-07-23 | 2013-09-04 | Oxford Nanopore Tech Ltd | Array of volumes of polar medium |
US11439708B2 (en) * | 2014-10-06 | 2022-09-13 | Lawrence Livermore National Security, Llc | Nanotube trans-membrane channels mimicking biological porins |
GB201418512D0 (en) * | 2014-10-17 | 2014-12-03 | Oxford Nanopore Tech Ltd | Electrical device with detachable components |
US9791432B2 (en) * | 2015-03-20 | 2017-10-17 | Genia Technologies, Inc. | Serpentine flow channels for flowing fluids over chip sensors |
US10739299B2 (en) * | 2017-03-14 | 2020-08-11 | Roche Sequencing Solutions, Inc. | Nanopore well structures and methods |
CN113061531B (en) * | 2021-06-03 | 2021-08-20 | 成都齐碳科技有限公司 | Chip structure, chip assembly, film forming method, nanopore sequencing device and application |
CN113070113B (en) * | 2021-06-03 | 2021-08-20 | 成都齐碳科技有限公司 | Chip structure, film forming method, nanopore sequencing device and application |
CN113402768B (en) * | 2021-07-06 | 2023-03-24 | 四川大学 | Phospholipid double-layer membrane for nanopore sequencing and preparation method thereof |
-
2022
- 2022-04-14 CN CN202410598638.3A patent/CN118835255A/en active Pending
- 2022-04-14 CN CN202210391473.3A patent/CN114908358B8/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN114908358A (en) | 2022-08-16 |
CN114908358B (en) | 2024-06-04 |
CN114908358B8 (en) | 2024-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6835892B2 (en) | Membrane array formation and equipment for it | |
CN108472647B (en) | microfluidic arrangement | |
JP4953044B2 (en) | Method and apparatus for forming lipid bilayer membrane | |
ES2225466T3 (en) | HOLDING DEVICE FOR A MOLD, HALF OF A MOLD OR A MOLD HOLDER IN AN INJECTION MOLDING MACHINE. | |
US8506905B2 (en) | Method of forming bilayer membrane by contact between amphipathic monolayers and apparatus therefor | |
JP7253045B2 (en) | Biopolymer analyzer and biopolymer analysis method | |
US20090058428A1 (en) | Method and device for monitoring and controlling fluid locomotion | |
US20130140192A1 (en) | Method of Producing a Lipid Bilayer and Microstructure and Measuring Arrangement | |
JP2001515216A (en) | Microstructure for manipulating fluid samples | |
US10386282B2 (en) | Method, apparatus and micro-rheometer for measuring rheological properties of newtonian and non-newtonian fluids | |
CN114908358B (en) | Preparation method and device of amphiphilic molecular layer | |
JP2005098718A (en) | Artificial lipid membrane formation method and lipid planar membrane formation apparatus therefor | |
CN117504956B (en) | Micro-nano fluidic chip and separation method of biochemical marker molecules | |
Nelson et al. | Monolithic fabrication of EWOD chips for picoliter droplets | |
Shim et al. | Formation of lipid bilayers inside microfluidic channel array for monitoring membrane-embedded nanopores of phi29 DNA packaging nanomotor | |
JP4410040B2 (en) | Microfluidic control mechanism and microchip | |
CN114225981A (en) | Ion selection membrane preparation device and method based on micro-droplet control chip | |
CN116809133B (en) | Chip flow channel structure, nanopore sequencing device and film forming method | |
WO2020260441A1 (en) | Microfluidic device and a method of manipulating droplets therein | |
JPWO2004008132A1 (en) | Biomolecule separation cell, method for producing the same, and DNA sorting apparatus | |
CN114807982B (en) | Preparation method and device of amphiphilic molecular layer | |
Nam | 200 mm wafer-scale fabrication of polydimethylsiloxane fluidic devices for fluorescence imaging of single DNA molecules | |
WO2021064084A1 (en) | Electrophoretic enrichment of analytes in droplets | |
CN110998310B (en) | Electrophoretic Separation of Biomolecules | |
EP3365108A1 (en) | Filler fluid for fluidic devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |